GENETIC MARKERS AND METHODS FOR THE DETECTION OF LISTERIA MONOCYTOGENES AND LISTERIA SPP

Abstract: A method, diagnostic sequences and primers are provided that are useful in identifying the Listeria monocytogenes and Listeria spp. The method involves identifying an RAPD-amplified DNA fragment common to Listeria monocytogenes, then identifying the most conserved regions of that DNA fragments, and the preparing specific primers useful for detecting the presence of a marker within the fragment whereby that set of primers is then useful in the identification of all Listeria monocytogenes. Markers within the same fragment that are specific to the Listeria genus are also identified and are useful for the identification of all Listeria spp.

Description: TITLE GENETIC MARKERS AND METHODS FOR THE DETECTION OF LISTERIA MONOCYTOGENES AND LISTERIA SPP This is a continuation-in-part of Application No 08/745228, filed 8 November 1996 FIELD OF INVENTION The invention relates to the field of molecular biology and the use of randomly amplified nucleic acid fragments (RAPD) for the selection of genetic markers useful in the identification of bacteria. More specifically, the invention relates to specific DNA marker sequences useful for the detection of Listeria monocytogenes and Listeria spp. and use of those diagnostic markers to determine if an unknown bacterium is a member of either Listeria monocytogenes or Listeria spp. BACKGROUND Central to the field of microbiology is the ability to positively identify microorganisms at the level of genus, species or serotype. Correct identification is not only an essential tool in the laboratory, but it plays a significant role in the control of microbial contamination in the processing of food stuffs, the production of agricultural products, and the monitoring of environmental media such as ground water. Increasing stringency in regulations that apply to microbial contamination have resulted in a corresponding increase in industry resources which must be dedicated to contamination monitoring. Of greatest concern is the detection and control of pathogenic microorganisms. Although a broad range of microorganisms have been classified as pathogenic, attention has primarily focused on a few bacterial groupings such as Escherichia, Salmonella, Listeria and Clostridia. Typically, pathogen identification has relied on methods for distinguishing phenotypic aspects such as growth or motility characteristics, and for immunological and serological characteristics. Selective growth procedures and immunological methods are the traditional methods of choice for bacterial identification and these can be effective for the presumptive detection of a large number of species within a particular genus. However, these methods are time consuming and are subject to error. Selective growth methods require culturing and subculturing in selective media, followed by subjective analysis by an experienced investigator. Immunological detection (e.g., ELISA) is more rapid and specific, however, it still requires growth of a significant population of organisms and isolation of the relevant antigens. For these reasons interest has turned to detection of bacterial pathogens on the basis of nucleic acid sequence II is well known, for example, that nucleic acid sequences associated with the πbosomes of bacteria are often highly conserved across genera and are therefore useful for identification (Webster, U S Patent No 4,717,653 and U S Patent No 5,087,558, Enns, Lab. Med.. 19, 295, ( 1988), ordarski, Soc. Appl. Bacteriol. Tech. Ser , 20 (Chem Methods Bact Sys ), 41, ( 1985)) Weisburg et al (EP 51736) disclose a method for the detection and identification of pathogenic microorganisms involving the PCR amplification and labeling of a target nucleotide for hybridization to 16S rDNA of E coli. Lane et al. (WO 9015157) teach universal nucleic acid probes that hybridize to conserved regions of 23 S or 16S rRNA of eubacteria. Although bacterial ribosomal nucleic acids contain highly conserved sequences, they are not the only sources of base sequence conservation that is useful for microorganism identification. Wheatcroft et al. (CA 2055302) describe the selection of transposable elements, flanked by unique DNA sequences, for the detection of various Rhizobium strains. Similarly, Tommassen et al. (WO 9011370) disclose polynucleotide probes and methods for the identification and detection of gram-positive bacteria. The method of Tommassen et al. relies on probes corresponding to relatively short fragments of the outer membrane protein, OmpA, which is known to be highly conserved throughout gram-positive genera. Atlas et al. (EP 517154) teach a nucleic acid hybridization method for the detection of Giardia sp. based on designing probes with sequences complementary to regions of the gene encoding the giardin protein. Webster et al. (U.S. Patent No. 4,717,653) has expanded upon the use of rRNA in disclosing a method for the characterization of bacteria based on the comparison of the chromatographic pattern of restriction endonuclease-digested DNA from the unknown organism with equivalent chromatographic patterns of at least 2 known different organism species. The digested DNA has been hybridized or reassociated with ribosomal RNA information-containing nucleic acid from (or derived from) a known probe organism. The method of Webster et al. effectively establishes a unique bacterial nucleic acid "fingerprint" corresponding to a particular bacterial genus against which unknown "fingerprints" are compared. Methods for the identification of Listeria monocytogenes on using specific hybridization probes or primers are known For example, U.S. 5523205 and JP 05219997 teach DNA probes capable of hybridizing to a portion of the genome of pathogenic Listeria monocytogenes, but do not hybridize to genomes of other Listeria species. DE 4238699 and EP 576842 teach methods for detection of Listeria monocytogenes using primers designed to give amplification products specific to the monocytogenes genome EP 576842 discusses a method for the detection of L monocytogenes using amplification primers based on genes encoding the highly conserved lap (invasion-associated protein) of Listeria and WO 9008841 teaches nucleic acid probes capable of hybridizing to ribosomal RNA (rRNA) or rDNA of Listeria and not to rRNA or DNA of non-Listeπa The methods described above are useful for the detection of bacteπa, but each relies upon knowledge of a gene, protein, or other specific sequence known a priori to be highly conserved throughout a specific bacteπal group An alternative method would involve a nontargeted analysis of bacterial genomic DNA for specific non-phenotypic genetic markers common to all species of that bacteria For example, genetic markers based on single point mutations may be detected by differentiating DNA banding patterns from restriction enzyme analysis. As restriction enzymes cut DNA at specific sequences, a point mutation within this site results in the loss or gain of a recognition site, giving rise in that region to restriction fragments of different length. Mutations caused by the insertion, deletion or inversion of DNA stretches will also lead to a length variation of DNA restriction fragments. Genomic restriction fragments of different lengths between genotypes can be detected on Southern blots (Southern, J. Mol. Biol. 98, 503, ( 1975)) The genomic DNA is typically digested with any restriction enzyme of choice, the fragments are electrophoretically separated, and then hybridized against a suitably labeled probe for detection. The sequence variation detected by this method is known as restriction length polymorphism or RFLP (Botstein et al., Am. J. Hum. Genet. 342, 314, (1980)). RFLP genetic markers are particularly useful in detecting genetic variation in phenotypically silent mutations and serve as highly accurate diagnostic tools. Another method of identifying genetic polymorphic markers employs DNA amplification using short primers of arbitrary sequence These primers have been termed "random amplified polymorphic DNA" or "RAPD" primers (see Williams et al., Nucl. Acids. Res., 18, 6531 (1990) and U.S. Patent No. 5,126,239; also EP 0 543 484 A2, WO 92/07095, WO 92/07948, WO 92/14844, and WO 92/03567) The RAPD method amplifies either double or single-stranded, nontargeted, arbitrary DNA sequences using standard amplification buffers, dATP, dCTP, dGTP and TTP, and a thermostable DNA polymerase such as Taq The nucleotide sequence of the primers is typically about 9 to 13 bases in length, between 50 and 80% G + C in composition and contains no palindromic sequences. RAPD detection of genetic polymoφhisms represents an advance over RFLP in that it is less time consuming, more informative, and readily susceptible to automation. Because of its sensitivity for the detection of polymoφhisms, RAPD analysis and variations based on RAPD PCR methods have become the methods of choice for analyzing genetic variation within species or closely related genera, both in the animal and plant kingdoms For example, Landry et al ( Genome. 36, 580, ( 1993)) discuss the use of RAPD analysis to distinguish various species of minute parasitic wasps that are not morphologically distinct Van Belkum et al. {Mol. Biochem Parasitoi , 61 , 69, ( 1993)) teach the use of PCR-RAPD for the distinction of various species of Giardi In commonly assigned U.S. Patent No. 5,340,728, Applicants disclosed a method of double-nested PCR which is used to detect the presence of a specific microbe. This disclosure first describes identifying a random, unique segment of DNA for each individual microorganism which will be diagnostic for that microorganism. To identify and obtain this diagnostic nucleic acid segment a series of polymoφhic markers is generated from each organism of interest using single primer RAPD analysis. The RAPD series from each organism is compared to similarly generated RAPD series for other organisms, and a RAPD marker unique to all members of the group is then selected. The unique marker is then isolated, amplified and sequenced. Outer primers and inner primers suitable for double-nested PCR of each marker may then be developed. These primers comprise sequence segments within the RAPD markers, wherein the inner set of primers will be complementary to the 3' ends of the target piece of nucleic acid. These nested primers may then be used for nested PCR amplification to definitely detect the presence of a specific microorganism. In commonly owned PCT U.S. 95/06704 (WO 95/33854), Applicants more particularly adapted and described this RAPD methodology to identify a sequence or marker. The presence of the marker is diagnostic for all individuals of the genus Salmonella. PCT U.S. 95/06704 teaches a method involving a RAPD amplification of genomic DNA of a representative number of Salmonella individuals to produce a RAPD amplification product, termed the diagnostic fragment. This diagnostic fragment must be present in the RAPD profiles in over 90% of the individuals tested. Sequence information from the diagnostic fragment enables identification of the most suitable PCR primer binding sites within the diagnostic fragment to define a unique diagnostic marker. Primers flanking this marker are useful for the generation of amplification products from Salmonella genomic DNA, but will not produce any amplification products in non-Salmonella genera. In commonly owned USSN 08/608,881, Applicants disclose a method, diagnostic sequences and primers that are useful in the identification of the Escherichia coli 0157:H7 serotype. The method involves the identification of a RAPD-amplified DNA fragment common to 0157:H7 Escherichia coli, the identification of the most conserved regions of that fragment, and the preparation of specific primers useful for detecting the presence of a marker within the fragment whereby that set of primers is then useful in the identification of all 0157 H7 Escherichia coli. The method of 08/608,881 does not teach markers useful for the specific identification of Listeria monocytogenes and Listeria spp. A detection methodology using PCR RAPD specific to Listeria monocytogenes and Listeria spp would be of high utility in the food industry Detection methods not dependent on sequences derived from a known gene or associated with a known phenotypic characteristic of Listeria monocytogenes and Listeria spp have not previously been disclosed SUMMARY OF THE INVENTION The present invention provides a method for the specific identification of Listeria monocytogenes and Listeria spp. using diagnostic genetic markers A method is provided for determining whether an unknown bacterium is a Listeria monocytogenes that involves: (A) amplifying genomic DNA from (i) a positive test panel of Listeria monocytogenes strains and (ii) a negative test panel of non- monocytogenes Listeria strains with a primer derived from a pre-marker diagnostic fragment for Listeria monocytogenes selected from the group of nucleic acids corresponding to SEQ LD NOS.17, 18, and 19 to yield a 1300 bp diagnostic fragment for each of the positive and negative test panels; (B) selecting at least one Listeria monocytogenes diagnostic marker contained within the diagnostic fragment by comparing the diagnostic fragment obtained from the amplification of the positive test panel with the diagnostic fragment obtained from the amplification of the negative test panel whereby at least one highly conserved region in the diagnostic fragment of the positive test panel is identified which is less than 90% homologous to any member of the negative test panel; (C) designing at least one amplification primer corresponding to the at least one diagnostic marker identified in step (B); and (D) amplifying genomic DNA of the unknown bacterium under suitable annealing temperatures with the at least one amplification primer of step (C), whereby obtaining at least one amplification product indicates that the unknown bacterium is a Listeria monocytogenes. The method preferably uses Listeria monocytogenes pre-marker diagnostic fragments selected from the group consisting of nucleic acids corresponding to SEQ LD NOS 20-23 The method preferably uses Listeria monocytogenes diagnostic fragments that are at least 83% homologous to SEQ ID NOS 24-31 and 3 -40 The method preferably uses diagnostic fragments selected from the group consisting of nucleic acids corresponding to SEQ ID NOS 24-3 1 and 33-40 The method preferably uses at least one diagnostic marker selected in step (B) selected from the group consisting of nucleic acids corresponding to SEQ ID NOS : 46-83. Preferably, the amplification primers used are about 15 to 30 bp in length and suitable annealing temperatures are in the range of about 60 °C - 70 °C. A method is also provided for determining whether an unknown bacterium is a member of the genus Listeria, comprising (A) amplifying genomic DNA from (i) a positive test panel of Listeria monocytogenes strains and (ii) a negative test panel of non-monocytogenes Listeria strains with a primer derived from a pre-marker diagnostic fragment for Listeria monocytogenes strains selected from the group consisting of nucleic acids corresponding to SEQ LD NOS: 17, 18 and 19 to yield a 1300 bp diagnostic fragment for each of the positive and negative test panels; (B) selecting at least one Listeria genus-specific diagnostic marker contained within the diagnostic fragment by comparing the diagnostic fragment obtained from the amplification of the positive test panel with the diagnostic fragment obtained from the amplification of the negative test panel whereby at least one highly conserved region in the diagnostic fragment of the positive test panel is identified which is at least 90% homologous to the corresponding positive test panel of diagnostic fragment; (C) designing amplification primers corresponding to the at least one Listeria genus-specific diagnostic marker selected in step (B); and (D) amplifying genomic DNA of the unknown bacterium under suitable annealing temperatures with the amplification primers of step (D), whereby obtaining amplification products indicates that the unknown bacterium is a member of the genus Listeria. The genus-specific method at step (A) preferably uses a diagnostic fragment 83% homologous to any one of SEQ LD NOS:24-31 and 33-40. The method at step (A) preferably uses a diagnostic fragment selected from the group consisting of nucleic acids coπesponding to SEQ LD NOS:24-31 and 33-40. The method preferably uses Listeria monocytogenes pre-marker diagnostic fragments selected from the group consisting of nucleic acids corresponding to SEQ LD NOS: 20-23. The method preferably uses diagnostic markers selected in step (B) from the group consisting of nucleic acids corresponding to SEQ LD NOS : 84- 110. Preferably, the method uses amplification primers of about 15 to 30 bp in length and uses a suitable annealing temperature in the range of about 60 °C to 70°C. Λ hybridization method for determining whether an unknown bacterium is a Listeria is provided compπsing contacting the genomic DNA of the unknown bacterium with a nucleic acid probe selected from the group consisting of nucleic acid sequences coπesponding to SEQ ID NOS 46-83, and then detecting hybridization of the nucleic acid probe with the genomic DNA A genus-specific hybridization method for determining whether an unknown bacteπum is a Listeria monocytogenes is provided compπsing contacting the genomic DNA of the unknown bacteπum with a nucleic acid probe selected from the group consisting of nucleic acid sequences corresponding to SEQ LD NOS 84- 110, and then detecting hybridization of the nucleic acid probe with the genomic DNA Isolated nucleic acid fragments are provided selected from the group consisting of nucleic acid fragments corresponding to SEQ LD NOS.17 through 110 Isolated nucleic acid fragments are provided encoding the amino acid sequence as given in any one of SEQ LD NOS.32 and 41-45 This invention further provides isolated nucleic acid fragments having SEQ LD NOS.17-110 A further embodiment of the invention are nucleic acid fragments located on a diagnostic fragment of about 1300 bp and selected from the group consisting of nucleic acid fragments designated 1515(rc341x2)-26-363, 1515(rc341x2)-27-281, 1515-26-36, 1515-27-357, 1515-26-rc233, 1515(8585)-27-rc737, 1515(8585)-28-rc793 1515-30-76, 1515-30-88, 1515(8585)-30-624, 1515(8585)-30-rc483, 1515(8585)-30-rc555, 1515(8585)-30-rc573, 1515(8585)-30-rc824, the diagnostic fragment characterized by (A) at least 83% homology to any one of SEQ LD NOS 24-31 and 33- 40, and (B) an open reading frame of about 855 bp contained within the diagnostic fragment, the open reading frame encoding an amino acid sequence of any one of SEQ ID NOS 32 and 1 -45 In greater detail, the methods involve the following steps (l) RAPD analysis The genomic DNA of positive and negative test panels of a representative number of individuals for Listeria monocytogenes was amplified using RAPD primers The positive test panel consisted of 20 strains of Listeria monocytogenes and the negative test panel consisted of 25 strains of non- monocytogenes Listeria spp RAPD amplification gave some amplification products specific to the positive test panel that were not seen in the negative test panel. The RAPD marker profiles from individuals of the positive test panel were compared with the RAPD marker profiles from individuals of the negative test panel and a nucleic acid fragment was selected where the fragment was present in all of the RAPD marker profiles from the positive test panel and absent in the RAPD marker profiles from the negative test panel. This fragment was termed a "pre-marker sequence" (ii) Sequencing: The nucleotides of the pre-marker sequence of step (i) were sequenced to identify available primer binding sites. (iii) Evaluation of the pre-marker sequence for Listeria monocytogenes specificity: Single primers derived from the pre-marker sequence were selected. These primers produced single amplification products when used to amplify genomic Listeria monocytogenes DNA. (iv) Determination and isolation of the diagnostic fragment: Sequences of the flanking regions of the pre-marker sequence were determined revealing a diagnostic fragment of 1300 bp. Sequencing of the diagnostic fragment in Listeria monocytogenes and non-monocytogenes Listeria revealed conserved regions specific both to Listeria spp. in general and Listeria monocytogenes in particular. Amplification primers were designed based on these conserved regions. (v) Preliminary selection of Listeria monocytogenes diagnostic primers on the basis of sensitivity to annealing temperature. Primers unique to Listeria monocytogenes were identified based on the diagnostic fragment. Primer pairs were selected on the basis of their ability to resist the formation of non- specific amplification products as annealing temperatures were reduced (vi) Final Selection of Listeria monocytosenes diagnostic primers The primers of step (v) were used in the amplification of genomic DNA from a large group of Listeria monocytogenes (positive test panel) and non- monocytogenes species (negative test panel) under specific annealing conditions, confirming the specificity of these primers for Listeria monocytogenes detection (vu) Preliminary Selectivity Testing for Listeria spp diagnostic primers Primers unique to Listeria spp were identified based on the diagnostic fragment Primer pairs were selected on the basis of their ability to specifically detect L. spp (viii) Selection of Listeria spp diagnostic primers on the basis of sensitivity to annealing temperature The pπmer pairs of step (vn) were screened on the basis of their ability to resist the formation of non-specific amplification products as the annealing temperatures were reduced. (xi) Final Selection of Listeria spp diagnostic primers The primers of step (viii) were used in the amplification of genomic DNA from a large group of Listeria spp. (positive test panel) and non-Listeria spp. (negative test panel) under specific annealing conditions, confirming the specificity of these primers for Listeria spp. detection. BRIEF DESCRIPTION OF THE FIGURES Figure 1 is a gel showing RAPD patterns for Listeria monocytogenes strains comprising both the negative and positive test panels, amplified with the 12-mer primer 12CN015. The specific lanes are identified in Table 3 Figure 2 shows a comparison of the amino acid sequences of L. monocytogenes #647, L. innocua DP #4450, L. seeligeri DP #3327, L. welshimeri DP #3359, and L. ivanovii DP #3340 Figure 3 shows the unique Listeria monocytogenes specific diagnostic primer sequences located at 1515(rc341x2)-26-363, 1515(rc341x2)-27-281, 1515-26-36, 1515-27-357, 1515-26-rc233, 1515(8585)-27-rc737, and 1515(8585)-28-rc793 and a comparison of priming site sequences for strains representing the following species. L. monocytogenes, L. innocua, L. seeligeri, L. welshimeri and L. ivanovii. Figures 4A-4C are gels illustrating the appearance of anomalous and false positive amplification products as the annealing temperature was reduced for the 1515-26-36/1515-26-rc233 primer pair The specific lanes are identified in Table 7 Figure 5A displays the PCR product patterns of Listeria monocytogenes strains from the positive test panel amplified with the primer pair 1515-27-357/1515(8585)-27-rc737 The specific lanes are identified in Table 8, column A. Figure 5B displays the PCR product patterns of Listeria monocytogenes strains from the negative test panel amplified with the primer pair 1 5 15-27-357/ 15 15(8585)-27-rc737 The specific lanes are identified in Table 8, column B Figure 6 is a gel showing the seven Listeria spp specific primer sequences located at 15 15-30-76, 15 15-30-88, 15 l 5(8585)-30-624, 15 l 5(8585)-30-rc483, 15 15(8585)-30-rc555, 1515(8585)-30-rc573, and 15 l 5(8585)-30-rc824 and a comparison of priming site sequences for strains representing the following species L. monocytogenes, L. innocua, L. seeligeri, L. welshimeri and L. ivanovii. Figure 7 is a gel showing Listeria spp. positive test panel response for PCR products generated from primer set 1515-30-76/1515(8585)-30-rc555. The specific lanes are identified in Table 1 1. Figure 8 is a gel showing Listeria spp. negative test panel response for PCR products generated from primer set 1515-30-76/1515(8585)-30-rc555. The specific lanes are identified in Table 12. Applicants have provided 110 sequence listings in conformity with 37 C.F.R. 1.821-1.825 and Appendices A and B ("Requirements for Application Disclosure Containing Nucleotides and/or Amino Acid Sequences") and in conformity with "Rules for the Standard Representation of Nucleotide and Amino Acid Sequences in Patent Applications" and Annexes I and LI to the Decision of the President of the EPO, published in Supplement No. 2 to the OJ EPO, 12/1992. Sequences of SEQ LD NOS: 1-16 are twelve-base arbitrary primers used in the generation of RAPD patterns. These are also shown in Table 1. Sequences of SEQ LD NOS: 17-19 are single primers derived from the pre-marker sequences. These are also shown at Table 2. SEQ LD NOS:20 and 21 represent the pre- marker sequence for strain #647 and SEQ LD NOS: 22 and 23 represent the pre- marker sequence for strain #1324. The amino acid composition for all L. monocytogenes strains is represented in SEQ LD NO:32. Sequences corresponding to SEQ LD NOS: 24-31 and 33-40 are diagnostic fragments; Sequences corresponding to SEQ LD NOS:32 and 41-45 are open reading frames encoding amino acid sequences. DETAILED DESCRIPTION OF THE INVENTION In the present method, Applicants have used RAPD amplification of Listeria monocytogenes and Listeria spp genomic DNA to discover diagnostic fragments and primers useful for the specific detection of Listeria monocytogenes and Listeria spp. The fragments are used to generate specific primers from the most conserved regions for use in a PCR assay that will produce amplification products specific to either Listeria monocytogenes or Listeria spp Applicant's method is distinctive in the following regard To selectively detect Listeria monocytogenes from all other Listeria or Listeria spp from all other bacteπa the method must be successful in determining the most conserved regions of the diagnostic fragments from a phenotypically uncharactenzed segment of D common to all Listeria monocytogenes or all Listeria spp One of skill in the an will recognize that conservation of sequence may be both an ally and an enemy in identifying the members of a particular genus For example, many bacteπal sequences are conserved across genera and these would not be useful in the determination of species within a particular genus It is precisely for that reason that methods previously known in the art rely pπmaπly on the analysis of sequences derived from proteins or genes known to be specific to a particular genus, l e , ribosomal RNA or toxin-encoding genes Applicant's method departs from the art in that the conserved sequences of the invention are not derived from a known gene nor is the sequence associated with any known phenotypic characteristic As used herein the following terms may be used for inteφretation of the claims and specification. "Nucleic acid" refers to a molecule which can be single-stranded or double- stranded, comprising monomers (nucleotides) containing a sugar, phosphate and either a purine or pyrimidine. In bacteria, lower eukaryotes, and in higher animals and plants, "deoxyribonucleic acid" (DNA) refers to the genetic material while "ribonucleic acid" (RNA) is involved in the translation of the information from DNA into proteins. The term "primer-directed amplification" refers to any of a number of methods known in the art that result in logarithmic amplification of nucleic acid molecules using the recognition of a specific nucleic acid sequence or sequences to initiate an amplification process Applicants contemplate that amplification may be accomplished by any of several schemes known in this art, including but not limited to the polymerase chain reaction (PCR) or ligase chain reaction (LCR) If PCR methodology is selected, the amplification method would include a replication composition consisting of, for example, nucleotide triphosphates, two pπmers with appropriate sequences, DNA or RNA polymerase and proteins These reagents and details describing procedures for their use in amplifying nucleic acids are provided in U S Patent No 4,683,202 (1987, Mullis et al ) and U S Patent No 4,683, 195 (1986, Mullis et al ) The term "pre-marker sequence" refers to a 414 bp fragment of DNA that is an internal region of the diagnostic fragment The term "derived from", with reference to an amplification primer, refers to the fact that the sequence of the primer is a fragment of the sequence from which it has been "derived" The fragment is always denoted in a 5' to 3' orientation The useful primer sequence size range for PCR amplification is about 15 base pairs to about 30 base pairs in length A "diagnostic fragment" refers to a particular DNA sequence which is highly conserved amongst the individuals of a particular genetically related population, for example, a genus, species, or serotype of bacteπa In the instant invention, the term "diagnostic fragment" is used to refer to the composite of that DNA fragment generated during RAPD amplification and those fragments that are generated from amplification with single primers derived from the pre-marker sequence, which are present in the RAPD and the single primer amplification profiles from either 1) all Listeria monocytogenes and absent from other Listeria spp or 2) present in all Listeria spp. but absent in profiles from non-Listeria species. The term "diagnostic marker" is used herein to refer to that portion of the diagnostic fragment which can be targeted to produce an amplification product only in either Listeria monocytogenes or Listeria spp. The diagnostic marker is present only in the organism to be identified at the desired classification level (i.e., species or genus) and attempts to amplify the diagnostic markers in individuals not so targeted will give no amplification product. Within the context of the present invention diagnostic fragments which are diagnostic markers for Listeria monocytogenes and Listeria spp. and useful in Applicant's invention include nucleic acid sequences SEQ LD NOS:24-31 and 33-40 of about 1300 bp containing an open reading frame of 855 bp, encoding the peptide as given in SEQ LD NO.32 The terms "conserved" or "highly conserved" refer to a level of similarity that exists between 2 or more nucleic acid fragments where there is at least 90% base similarity between the fragments. The term "base similarlity" refers to the relatedness between the nucelotide sequence of two nucleic acid molecules. Estimates of such similarity are provided by either DNA-DNA or DNA-RNA hybridization under conditions of stringency as is well understood by those skilled in the art (Sambrook et al , Molecular Cloning. A Laboratory Manual, volumes 1, 2, 3 (Cold Spring Harbor Laboratory, Cold Spring Harbor, New York)) The term "primer" refers to a nucleic acid fragment or sequence that is complementary to at least one section along a strand of the sample nucleic acid, wherein the puφose of the primer is to sponsor and direct nucleic acid replication of a portion of the sample nucleic acid along that strand Pπmers can be designed to be complementary to specific segments of a targeted sequence In PCR, for example, each primer is used in combination with another pπmer forming a "primer set" or "primer pair", this pair Hanks the targeted sequence to be amplified In RAPD amplification, single arbitrary primers are used to amplify nontargeted segments of nucleic acid which are located between the pπmer sequence sites in opposing DNA strands The term "primer", as such, is used generally by Applicant to encompass any sequence-binding oligonucleotide which functions to initiate the nucleic acid replication process "Diagnostic primers" will refer to primers designed with sequences complementary to primer binding sites on the diagnostic marker Diagnostic primers are useful in the convenient detection and identification of diagnostic markers specific to Listeria monocytogenes and Listeria spp. A "genetically related population" refers to any grouping of microorganisms possessing multiple or single genotypic or phenotypic characteristics of sufficient similarity to allow said organisms to be classified as a single genus, species, or subspecies of bacteria. For puφoses of the present disclosure, examples of genetically related populations include, for example, Listeria monocytogenes and Listeria spp. A "test panel" refers to a particular group of organisms or individuals selected on the basis of their genetic similarity to each other or on the basis of their genetic dissimilarity to another group (i.e., another genus, species, subspecies or serotype). A "positive test panel" will refer to a number of individuals selected for the desired genetic similarity between those individuals and, in the instant case, will be comprised of individuals of either Listeria monocytogenes or Listeria spp. Similarly, a "negative test panel" will refer to a test panel selected on the basis of genetic diversity between its members and the members of the positive test panel. A suitable negative test panel in the present invention would be comprised of non-Listeria monocytogenes where L. monocytogenes is the target organism or non-Listeria spp. where Listeria spp. is the target organism. The term "unknown microorganism" or "unknown bacterium" is a microorganism or bacterium whose identity is undetermined. The term "amplification product" refers to specific DNA fragments generated from any primer-directed nucleic acid amplification reaction The diagnostic markers of the present invention are amplification products generated in PCR reaction using diagnostic primers and are useful for the detection of Listeria monocytogenes and Listeria spp. The term "RAPD" refers to "random amplified polymoφhic DNA" "RAPD amplification" refers to a method of single primer-directed amplification of nucleic acids using short primers of arbitrary sequence to amplify nontargeted, random segments of nucleic acid The method is disclosed and claimed in U S Patent No. 5, 126,239 "RAPD method" or "RAPD analysis" refers to a method for the detection of genetic polymorphisms involving the nontargeted amplification of nucleic acids using short primers of arbitrary sequence, whereby the profile or pattern of "RAPD" amplification products is compared between samples to detect polymorphisms. "RAPD primers" refers to primers of about 8 to 13 bp, of arbitrary sequence, useful in the RAPD amplification or RAPD analysis according to the instant method. The "RAPD marker profile" refers to the pattern, or fingeφrint, of amplified DNA fragments which are amplified during the RAPD method and separated and visualized by gel electrophoresis. The term "ribotype" refers to a specific classification of bacteria or other microorganisms based on the digestion of genomic DNA with a restriction endonuclease, electrophoretic resolution of the restricted DNA and visualization of those fragments containing rDNA sequences by means of hybridization with a probe derived from the rDNA operon. The diagnostic marker of the invention can be used to identify any member of either Listeria monocytogenes to the exclusion of other Listeria spp., or Listeria spp. to the exclusion of all other bacteria. In the present invention, diagnostic primers flanking the marker are useful to amplify the marker using PCR. • Alternatively, nucleic acid probes could be developed based upon some or all of the diagnostic marker sequences and thus used to detect the presence of the marker sequence using standard solid phase or solution nucleic acid hybridization and reporter methods. It is contemplated that regions of about 30 base pairs or more of the diagnostic marker, especially encompassing the primer regions could be used as sites for hybridization of diagnostic probes. These methods might be used specifically for the detection of Listeria monocytogenes or Listeria spp. in food, human or animal body fluids or tissues, environmental media or medical products and apparatti. The instant method is more particularly described below with reference to the specific method steps as provided in the Summary of the Invention. Selection of RAPD Primers and Detection of Diagnostic Fragment in Members of the Positive and Negative Test Panels, step (P): Genomic DNA isolated from positive and negative test panels of microorganisms was subjected to RAPD amplification using sixteen 12-base primers of arbitrary sequence. The positive test panel consisted of 20 strains of Listeria monocytogenes and is described in detail in the GENERAL METHODS section below. The negative test panel consisted of a variety of 25 Listeria spp. and is also described in the GENERAL METHODS section below. Techniques for the isolation of genomic DNA are common and well known in the art and examples may be found in Sambrook et al , Molecular Cloning A Laboratory Manual - volumes 1, 2, 3 (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York ( 1989)) RAPD primers of 12 bases in length were used because at this primer length the RAPD patterns generally contained one to five amplified DNA fragments Use of shorter primers frequently resulted in a large number of amplification products, which made the extraction of a single homogeneous fragment for sequencing much more difficult. When primers of greater than 12 bases were used a significant fraction of the bacterial strains produced no RAPD products which would have necessitated the screening of a much larger number of arbitrary primers. One of the primers, designated 12CN015 (Table I, GENERAL METHODS), was found to produce a 414 bp amplification product (termed a pre-marker sequence) in all of the positive test panel. 12CN015 had the sequence of GGA CAG AGC ATA (SEQ LD NO: 15). The primer, 12CN15, was found to produce a 414 bp amplification product in all L. monocytogenes strains. This 414 bp pre-marker sequence was not observed in the amplification products of the negative test panel using the same primer. Examples of the 12CN15 RAPD patterns for strains of both test panels is shown in Figure 1. Sequencing of Pre-marker Sequence, step (ii): Since the 414 bp product was unique to L. monocytogenes, samples of this product were isolated for two strains different of L. monocytogenes, DP #647 and DP #1324, and the respective products sequenced. The two strains represented a ribotype that was highly polymoφhic (#1324) based on RAPD patterns and a ribotype that is pathogenic (#647). The object of selecting a common pathogenic strain and a polymoφhic strain of L. monocytogenes, was to characterize the genetic diversity likely to be found within the 12CN15 marker fragment. The complete sequences of the 414 bp products for DP #647 and #1324, including the flanking 12CN15 sequences, are shown in SEQ LD NOS:20 and 21 for DP #647 and SEQ LD NO:21 and 23 for DP #1324. Comparison of the DP #647 and #1324 sequences shows a 98% homology. Both sequences appear to be an internal section of an open reading frame (ORF) with the same amino acid composition. Evaluation of Pre-marker Sequence for Listeria monocvtosenes Specificity, step (iii): The puφose of the initial PCR screening was to identify sequence domains that demonstrated species selectivity Primers based on the 414 bp pre-marker sequences were first evaluated for their ability to specifically amplify from L. monocytogenes genomic DNA. Initial primer sequences were 26 bases long with a GC composition of 50 ~ 5 to allow for an annealing temperature in the range of 70 °C Pnming sites were selected within a distance of 200 bases from each 12CN15 priming site These sequences were examined to insure that inter- and intra-primer interactions were minimized to avoid the production of nonspecific PCR amfacts Many of the initial pπmer pairs that were tested generated multiple amplification products from genomic L. monocytogenes DNAs Multiple PCR products can occur when at least 8 bases of one 3' primer sequence appears as an inverted repeat in the region adjacent to the originally targeted priming sites To determine which products were the result of inverted repeats of a single primer sequence and which primers were responsible for these products, amplification reactions were run using single primers. A significant number of single primers such as 1515-26-85, (SEQ LD NO: 17) 1515-26-rc292 (SEQ LD NO: 18) and 1515-26-rc341 (SEQ LD NO: 19) (Table 2) were capable of generating PCR products in single primer amplifications. Determination and Isolation of the Diagnostic Fragment, step (iv): Determination of sequences adjacent to the RAPD marker Each of the single primers, 1515-26-85, (SEQ LD NO: 17) 1515-26-rc292 (SEQ LD NO: 18) and 1515-26-rc341 (SEQ LD NO: 19) generated a PCR product that contained part of the original 414 bp fragment plus additional sequence. Sequence determination of these augmented CN15 fragments was accomplished by means well known in the art. Sequencing revealed approximately 900 bases of additional sequence. The new sequence consisted of 400 bases in the region preceding the original 12CN15 site and 500 bases in the region following the second 12CN15 site revealing a complete open reading frame (ORF). The degree of conservation within this genetic locus was further examined by amplification of additional Listeria monocytogenes strains and comparison of those amplification products with the strains already sequenced. Comparison revealed that all strains contain a 1300 bp diagnostic fragment containing a complete open reading frame of 855 bases. This sequence was used as the diagnostic fragment and is identified by SEQ LD NOS:24-31. To determine if this fragment contained selective priming sites for Listeria monocytogenes specific primers, further analysis of the sequence composition was done to determine if it was distinct from other Listeria spp BASE SIMILARITY COMPARISON BETWEEN 1300BP DIAGNOSTIC FRAGMENTS A comparison of the base similarity between all isolated 1300 bp diagnostic fragments is given below 4647 # 1324 #4450 #654 #3327 #3340 L MONO #647 97 1% 86 8% 84 5% 83 3% 83 0% L MONO #1324 86 6% 84 4% 83 6% 82 7% L INN #4450 85 9% 84 3% 82 9% L WELSH. #654 83 2% 82.9% L. SEEL #3327 86 1% L. IVAN #3340 Sequencing marker fragment for other Listeria species - determination of sequence composition of diagnostic fragment Evaluation of primer sites in the 1300 bp diagnostic fragment showed that not all primer sites were specific for Listeria monocytogenes, suggesting conservation of the sequence composition at the genus level. The genetic composition was explored by isolating and sequencing the 855 bp fragment and the flanking regions from a panel of non-monocytogenes strains. All strains were found to contain the 855 base open-reading frame. However, a comparison of the sequences demonstrated there were species- dependent differences in the nucleic acid composition within the ORF SEQ LD NOS: 33-40 and Table 3, Example 3). The specific locations of these differences suggest priming sites where the diversity of nucleotide sequence may be sufficient to allow for selective priming of Listeria monocytogenes strains Preliminary selection of Listeria monocytogenes diagnostic primers on the basis of sensitivity to annealing temperature, step (v A comparison of sequence data for the five L. spp. made it possible to identify seven priming sites that were unique to L. monocytogenes. These priming sites were as follows; 1515(rc341x2)-26-363, 1515(rc341x2)-27-281, 1515-26-36, 1515-27-357, 1515-26-rc233, 1515(8585)-27-rc737, and 1515(8585)-28-rc793 (Figure 3) 26 to 30 bases in length depending on the GC composition. Longer primers were used for sites with a GC composition of < 50% to assure that a 70 °C annealing temperature could be maintained. Figure 7 shows the primer sequences and a comparison of priming site sequences for strains representing the following species L. monocytogenes, L. innocua, L. seeligeri, L. welshimeri and L. ivanovii To minimize the likelihood that L. monocytogenes selective primers would generate PCR products from mismatched priming in non-monocytogenes strains, the relationship between annealing temperature and selectivity was evaluated A test panel consisting of both Listeria monocytogenes and non-monocytogenes strains was prepared and amplifications were carried out over a range of temperatures and analyzed for the appearance of amplification products from Listeria spp. that were non-monocytogenes Primer pairs that showed an onset of non-specific amplification at or above 65 °C were considered as unsuitable for use as Listeria monocytogenes diagnostic primers Final selection of Listeria monocytogenes diagnostic primers, step (vi) Before making the final primer selection, the accuracy of all candidate primer sets was evaluated for a larger group of L. monocytogenes strains A set of 323 strains of L. monocytogenes was used to evaluate the inclusivity of the following primer sets: 1) 1515-27-357/1515(8585)-27-rc737; 2) 1515-27-357/1515(8585)-28-rc793; and 3) 1515(rc341x2)-26-(-363)/1515-26- rc233 (Figure 3). Accuracy in detection of Listeria monocytogenes ranged from 99.5% to 100%) depending on the primers and amplification conditions used. None of the three primer sets generated amplification products for the 30 non- monocytogenes strains in the annealing stringency test panel. Preliminary selectivity testing of Listeria spp diagnostic primers, step (vii): A comparison of sequence data for the five above-mentioned Listeria species made it possible to identify seven priming sites present in strains representing these species that were at least 90% homologous to L. monocytogenes. These priming sites were as follows: 1515-30-76, 1515-30-88, 1515(8585)-30-624, 1515(8585)-30-rc483, 1515(8585)-30-rc555, 1515(8585)-30-rc573, and 1515(8585)-30-rc824 (Figure 6). Primers to these sites were made 30 bases in length to compensate for mismatches in sequence and to assure that a 70 °C annealing temperature could be maintained. Before evaluating stringency conditions, the accuracy of all candidate primer sets was evaluated for a group of 33 L. spp. strains. These strains were used to evaluate the inclusivity of the following primer sets: 1) 1515-30-76/1515(8585)-30-rc483, 2) 1515-30-76/1515(8585)-30-rc555; 3) 1515-30-76/1515(8585)-30-rc573, 4) 1515-30-76/1515(8585)-30-rc824; 5) 1515-30-88/1515(8585)-30-rc483, 6) 1515-30-88/1515(8585)-30-rc555, 7) 1515-30-88/1515(8585)-30-rc573,8) 1515(8585)-30-624/l 515(8585)-30-rc824. The accuracy in the detection of . spp was 100% for the following primer sets. 1515-30-76/1515(8585)-30-rc555, 1515-30-76/1515(8585)-30-rc573, 1515-30-88/1515(8585)-30-rc555, and 1515-30-88/1515(8585)-30-rc573 Selection of Listeria spp diaunostic primers on the basis of sensitivity to annealing temperature, step (viii) As with Listeria monocytogenes, the relationship between annealing temperature and selectivity was evaluated to minimize the generation of non- specific amplification products This test was performed for all the primer pairs that scored 100% in the preliminary inclusivity evaluation Amplifications were carried out on a test panel of 7 strains of Listeria spp. and non- . spp. at an annealing temperature of 70 °C Annealing temperature was then decreased in 5 °C increments until the onset of nonspecific amplification products. The 1515-30-76/1515(8585)-30-rc555 primer set was found to be the least likely to generate nonspecific amplification products. Final selection of Listeria spp. diagnostic primers, step (ix): Before confirming the selection of the 1515-30-76/1515(8585)-30-rc555 primer set, the accuracy of this primer set was evaluated for a group of 73 L. spp. strains. Accuracy in detection of L. monocytogenes, L. innocua, L. welshimeri, L. seeligeri, and L. ivanovii was 100%. This primer set did not generate amplification products for the 65 non-Listeria spp. strains in the non-Listeria test panel. To determine whether the selected primer set would generate PCR products from mismatched priming in non-monocytogenes strains, the relationship between annealing temperature and selectivity was evaluated. A test panel consisting of both Listeria spp. and non-L. spp. strains was prepared and amplifications were carried out over a range of temperatures and analyzed for the appearance of amplification products from non-L. spp. In this fashion, it was determined that 60 °C is the lowest annealing temperature that will result in specificity for L. spp. , and 70 °C is the preferred temperature that should be used when using this set of Listeria spp. specific primers. EXAMPLES GENERAL METHODS Procedures for DNA amplifications and other protocols common in the art of molecular biology used in the following examples may be found in Sambrook, J. et al., Molecular Cloning: A Laboratory Manual. Second Edition, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY (1989). Materials and methods suitable for the maintenance and growth of bacterial cultures are well known in the art. Techniques suitable for use in the following examples may be found in Manual of Methods for General Bacteriology (Phillipp Gerhardt, R. G E Murray, Ralph N Costilow, Eugene W Nester, Willis A. Wood, Noel R. Krieg and G Briggs Phillips, eds), American Society for Microbiology, Washington, DC (1994) or in the work of Thomas D Brock (in Biotechnology A Textbook of Industrial Microbiology. Second Edition ( 1989) Sinauer Associates, Inc , Sunderland, MA) All reagents and materials used for the growth and maintenance of bacteπal cells were obtained from Aldπch Chemicals (Milwaukee, WI), DIFCO Laboratories (Detroit, MI), GIBCO/BRL 5 (Gaithersburg, MD), or Sigma Chemical Company (St Louis, MO) unless otherwise specified The meaning of abbreviations is as follows "h" means hour(s), "mm" means mιnute(s), "sec" means second(s), "d" means day(s), "mL" means milliliters, "L" means liters 10 DNA sequencing was performed by Lark Sequencing Technologies Inc., (Houston, Texas) or according to the method of Sanger et al. (Proc. Natl. Acad. Sci., USA 74, 5463, (1977)) using fluorescence-labeled dideoxynucleotides and the Genesis 2000™ DNA Analysis System (E. I. du Pont de Nemours and Company, Wilmington, DE). 15 Construction of Positive and Negative Test Panels Listeria monocvtosenes A positive test panel consisting of 20 genotypically different Listeria monocytogenes strains was constructed for the identification of a Listeria monocytogenes and Listeria spp. RAPD marker. The Listeria monocytogenes 20 strains of the postive test panel encompassed all commonly encountered serotypes and included L. monocytogenes, DP #647, #899, #1324 and #3386. The negative test panel consisted of 25 different Listeria non- monocytogenes strains comprising the species L. innocua, L. seeligeri, L. welshimeri, L. grayi, L. murrayi and L. ivanovii. 25 RAPD Primers RAPD primers used for amplification of genomic DNA from the positive and negative test panels are given below in Table 1 TABLE 1 Twelve-Base Arbitrary Pnmers Used m the Generation of RAPD Patterns CN01- AGC TGA TGC TAC SEQ ID NO : l 12CN09- AAC CTC GTG TAG SEQ ID NO : 9 CN02- AGT CGA ACT GTC SEQ ID NO : 2 12CN10- CAT TCG GGT ACA SEQ ID NO : 10 CN03- TTA GTC ACG GCA SEQ ID NO : 3 12CN11- GCC CTT AGT GAA SEQ ID NO : 11 CN04- TGC GAT ACC GTA SEQ ID NO : 4 12CN12- GCA GTT ATG ACC SEQ ID NO : 12 CN05- CTA CAG CTG ATG SEQ ID NO : 5 12CN13- CCA GCT ATC TCT SEQ ID NO : 13 CN06- GTC AGT CGA ACT SEQ ID NO : 6 12CN14- AGA AGG CAG TTG SEQ ID NO : 14 CN07- GGC ATT AGT CAC SEQ ID NO : 7 12CN15- GGA CAG AGC ATA SEQ ID NO : 15 CN08- CGT ATG CGA TAC SEQ ID NO : 8 12CN16- CGT TTC GCT TCA SEQ ID NO : 16 Primer Nomenclature Primers names identified in the following examples are derived in the following manner The first number, 15 15, indicates the primer sequence comes from the RAPD fragment primed at both ends by 12CN 15 The second number indicates the primer length The third number identifies the 3' base position of the pπmer, where position 1 is at the 5' end of the original putative 12CN 15 pπming site The re designation means that the pπming site is located on the complementary strand Primer locations may also be referred to by the last number of the identifying number Thus " 1515-26-85" may be referred to as "85" RAPD primers may be referred to with out the "12" designation Thus "12CN15" may also be referred to as "CN15" The primers described below in Table 2 are derived from the pre-marker sequence. As single primers they match the pre-marker sequence and they also match at least the last 9 bases of 3' sequence at another location outside of the pre- marker sequence. The net effect is that these primers will generate amplification products in single primer reactions from genomic DNA. These products contain part of the original 414 bp fragment plus additional sequence. EXAMPLE 1 ISOLATION OF PRE-MARKER SEQUENCE FROM LISTERIA MONOCYTOGENES BY RAPD ANALYSIS Example 1 details the isolation of the 414 bp pre-marker sequence from Listeria monocytogenes genomic DNA using Random Amplified Polymoφhic DNA RAPD primer analysis. A set of eight 12-base primers (Table I) was used in a RAPD analysis of 20 strains of Listeria monocytogenes The results of these amplifications were examined for a Listeria monocytogenes-snecific amplification product that could be easily separated from other RAPD products The amplification and data acquisition protocol ror each 12-base primer RAPD reaction was as follows Amplification protocol For each 50 uL reaction, 1 5 uL - dNTP mix (5 mM dNTP each), 36 3 μL - deionized water, 5 uL - 10X reaction buffer (500 mM KC1, 100 mM tπs pH 8 3, 15 mM MgCI 2 , 0 003% gelatin), 5 μL - primer ( 10 mM), 0 4 μL - Taq polymerase (5 U/μL), and 1 2 uL - Taq dilution buffer ( 10 mM tπs @ pH 8 0 and 1 0% Tween 20) were combined A 1 0 μL aliquot of genomic bacteπal DNA @ 50 ng/μL was added to each mixture The reaction was heated to 94 °C for 2 min Twenty-eight cycles of the following temperature profile were run 15' @ 94 °C, 5' @ 46 °C, 2' ramp to 72 °C, and 1' @ 72 °C At the end of cycling the reaction was incubated at 72 °C for 7 min After amplification a 5 μL aliquot of the reaction was combined with 2 μL of Ficol-loading buffer and run on a 4% acrylamide gel (29 1)/1 Ox TBE Follow-mg electrophoresis, the gels were stained with ethidium bromide The stained gels were placed on a transilluminator and electronically imaged with a high sensitivity CCD camera. Images were stored in computer memory for subsequent analysis Analysis The primer, 12CN15, (SEQ LD NO 15) was found to produce a 414 bp (SEQ LD NO 32) amplification product in all L. monocytogenes strains This 414 bp fragment was not observed in the amplification products of the negative test panel using the same primer Examples of the 12CN15 RAPD patterns for strains of both test panels is shown in Figure 1 The lanes are correlated to Figure 1 as follows in Table 3 TABLE 3 Lane Strain Lane Strain 1 L. welshimeri #943 13 L. ivanovu #1165 2 L. monocytogenes #945 14 L. monocytogenes #1281 3 L. seeligeri #949 15 L. monocytogenes #1287 4 L. innocua #950 16 L. seeligen #1290 5 L. monocytogenes #1047 17 L. monocytogenes #1283 6 L. seeligen #1059 18 L. monocytogenes #1295 7 L. seeligen #1061 19 L. monocytogenes #1299 8 L. monocytogenes #1068 20 L. seeligen #1303 9 L. monocytogenes #1069 21 L. monocytogenes #1313 10 L. monocytogenes #1070 22 L. seeligen #1317 11 L. innocua #1089 23 L. monocytogenes #1324 12 L. innocua #1157 24 L. monocytogenes #1963 * Arrows denote 414 bp product in L. monocytogenes strains (See Lanes 2. 5, 8, 10, 14, 15, 18, 19 21 and 24 of Figure 1 ) As is evident from Figure 1 , the positive test panel produced a characteristic amplification product of 414 bp which appeared in all of the 20 Listeria monocytogenes strains tested Additionally it is seen that none of the negative test panel group showed the 414 bp amplification product seen in the positive test panel EXAMPLE 2 GENERATION OF THE DIAGNOSTIC FRAGMENT FROM SEQUENCE FLANKING THE PRE-MARKER SEQUENCE Example 2 illustrates the sequencing of the flanking regions of the 414 bp pre-marker sequence using single primers and the generation of the diagnostic fragment The 414 bp pre-marker sequence of Example 1 was commercially sequenced from two strains of Listeria monocytogenes (#647 and #1324) described above. The pre-marker sequence for each strain is given in SEQ LD NOS:20 and 21 for #647 and SEQ LD NOS:22 and 23 for #1324. Primers were designed based on the pre-marker sequence, and evaluated for their ability to specifically amplify from Listeria monocytogenes genomic DNA. Initial primer sequences were 26 bases long with a GC composition of 50 + 5% to allow for an annealing temperature in the range of 70 °C. Priming sites were selected within a distance of 200 bases from each 12CN15 priming site. Following this method three single primers were identified as 1515-26-85 (SEQ LD NO: 17), 1515-26-rc292 85 (SEQ LD NO: 18), and 1515-26-rc341 85 (SEQ LD NO: 19), (Table 2) which generated a PCR product in the absence of a second primer. Each of these single primers generated a PCR product that contained part of the original pre-marker sequence plus additional sequence. Sequence of these augmented 12CN15 fragments was accomplished using the chain-termination method of Sanger et al. (Proc. Natl. Acad. Sci. , USA 74, 5463, (1977)) using fluorescence-labeled dideoxynucleotides and the Genesis 2000™ DNA Analysis System (E. I. du Pont de Nemours and Company, Wilmington, DE). The new sequence consisted of 400 bases in the region preceding the original 12CN15 site and 500 bases in the region following the second 12CN15 site This sequence data made it possible to identify a complete ORF plus several hundred bases upstream and downstream from the reading frame. To further characterize the degree of conservation within this genetic locus, nucleic acid sequences were determined for two additional strains of L. monocytogenes, DP #899 and DP #3386 DP #899 is an additional representative of a known pathogenic L. monocytogenes ribotype group DP *3386 is a strain of a less pathogenic L. monocytogenes ribotype group Sequencing of these strains was accomplished using the chain-termination method of Sanger et al,, (supra) and the Genesis 2000™ DNA .Analysis System The complete sequences for the L. monocytogenes strains, DP #647, #899, s i 324 and 86, are shown in SEQ ID NOS 24-3 1 (The 5' end of the original CN15 priming site was designated as base number 1 to provide a common reference point for all of the sequence data.) Analysis of the nucleic acid sequence showed that all four strains contained a complete open reading frame of 855 bases. Within this ORF DP #647, #899, and #3386 all showed identical nucleic acid sequences. DP #1324 is 97% homologous with the other three L. monocytogenes strains. When the nucleic acid sequences were translated into the corresponding amino acid sequence DP #1324 was found to be identical to the other three strains. The amino acid composition for all of the L. monocytogenes strains is shown in SEQ LD NO:32). The promoter and the terminal spacer sequences for DP #647, #899, and #3386 were also identical. DP #1324 shows an homology of 98% and 96% with the promoter and the terminal spacer, respectively. This genetic locus and the surrounding region showed a high level of conservation among strains of L. monocytogenes. Further analysis of the sequence composition of the 1300 bp diagnostic fragment containing the 855 bp ORF was needed to determine if it was sufficiently distinct from other L. spp so as to provide selective priming sites for a PCR-based assay for L. monocytogenes. EXAMPLE 3 DETERMINATION OF SEQUENCE COMPOSTITION OF DIAGNOSTIC FRAGMENT BY COMPARISON OF MARKER FRAGMENT SEQUENCE WITH OTHER LISTERIA SPECIES A preliminary evaluation of primer sites in the augmented CN15 marker demonstrated that many locations did not discriminate between L. monocytogenes and other L. spp. This observation suggested that much of the sequence composition of this genetic locus was conserved at the genus level. To determine whether this genetic locus contained any sequences that were unique to L. monocytogenes, strains representing L. innocua, L. seeligeri, L. welshimeri and L. ivanovii were also selected for sequencing. (Marker sequences were not determined for L. grayi and L. murrayi because these species were considerably more polymorphic than other L. spp.) Previously determined non-selective priming sites were used to generate quantities of DNA suitable for sequencing. As with I. monocytogenes, primers 1515-26-85, (SEQ LD NO: 17), 1515-26-rc292 ( SEQ ID NO 18), and 15 15-2b-rc341 (SEQ ID NO 19), used in single pπmer amplifications also generated PCR products suitable for sequencing Sequencing was accomplished using the chain-termination method of Sanger et al , and the Genesis 2000™ DNA Analysis System A compaπson of the nucleotide sequences showed that each of the above species contained an 855 base open-reading frame However, there were some species dependent differences in the nucleic acid composition within the ORF Sequences SEQ LD NOS 33-40 show the nucleic acid composition for the following strains L. innocua DP #4450, L. seeligeri DP #3327, L. welshimeri DP #3359, and L. ivanovii DP #3340, respectively These differences in nucleotide sequence are responsible for corresponding species variations in amino acid sequence. The nucleotide and amino acid sequence homology is summarized in Table 4. Figure 2 shows a comparison of the amino acid sequences of each L. spp , including L. monocytogenes. TABLE 4 Open Reading Frame Nucleotide and Amino Acid Seαuence Comoarison between Listeria Species Nucleotide Homology to Amino Acid Homology to Species L. monocytogenes M I L. monocytogenes #647 L. innocua 86.7% 95.8% L. seeligeri 84.5% 94.0% L. welshimeri 83.8% 93.7% L. ivanovii 83.3% 93.3% Of the L. spp. that were tested, L. innocua clearly showed the greatest similarity to L. monocytogenes. The remaining three species all showed roughly comparable levels of divergence in nucleotide and amino acid composition. The promoter and terminal spacer nucleic acid sequences also showed significant differences between species. The homologies of promoter and spacer sequences compared to L. monocytogenes are summarized in Table 5 TABLE 5 Promoter and Terminal Spacer Sequence Comparison between L. Spp. Promoter Homology to Terminal Spacer Homology to Species L. monocytogenes #647 L. monocytogenes #647 L. innocua 91.9% 79 4% L. seeligeri 85 0% 75 4% L. welshimeri 90 9% 75 5% L. ivanovii 83 7% 84 0% The homology to L. monocytogenes found in promoter and terminal spacer sequences is significantly different from that observed for the open reading frame sequences L. innocua and L. welshimeri both show homologies to L. monocytogenes in the promoter region that are significantly greater than the corresponding ORF homology For L. seeligeri and L. ivanovii the promoter regions and ORF regions both show comparable levels of homology with L. monocytogenes. In three species the terminal spacer sequences show a notable decrease in homology compared to the promoter regions and open reading frames, while in L. ivanovii similar levels of homology to L. monocytogenes are found in all three regions. EXAMPLE 4 SELECTION OF LISTERIA MONOCYTOGENES DIAGNOSTIC PRIMERS ON THE BASIS OF SENSITIVITY TO ANNEALING TEMPERATURE Identification of Priming sites and Primer synthesis: A comparison of sequence data for the five L. spp. (Example 3) made it possible to identify seven priming sites that were unique to L. monocytogenes. These priming sites were as follows: 1515(rc341x2)-26-363, 1515(rc341x2)-27-281, 1515-26-36, 1515-27-357, 1515-26-rc233, 1515(8585)-27-rc737, and 1515(8585)-28-rc793 (Figure 3). "Uniqueness" is defined as any sequence region of 26-30 bases where the homology between L. monocytogenes and any other Listeria spp. is less than 90%. Primers were synthesized to correspond to these sites and ranged in length from 26 to 30 bases depending on the GC composition. Longer primers were used for sites with a GC composition of <50% to assure that a 70 °C annealing temperature could be maintained. Figure 3 shows the primer sequences and a comparison of priming site sequences for strains representing the following species: L. monocytogenes, L. innocua, L. seeligeri, L. welshimeri and L. ivanovii. Determination of annealing termperature: To minimize the likelihood that L. monocytogenes-seϊecύve primers would generate PCR products from mismatched priming in non-monocytogenes strains, the relationship between annealing temperature and selectivity was evaluated. A 33 -strain test panel consisting of 15 L. innocua, 5 L. welshimeri, 6 L. seeligeri, 3 L. ivanovii, 1 L. grayi and 3 L. monocytogenes was prepared. Amplifications were first carried out at an annealing temperature of 70 °C. Annealing temperature was then decreased in 5 °C increments until amplification products began to appear for the non-monocytogenes strains. The amplification and detection protocol is summarized below Combine 1 5 uL - dNTP mix (5 mM each dNTP), 40 uL - deionized water, 5 μ L - 10X reaction buffer (500 M KC1, 100 mM tπs @ pH 8 3. 15 mM MgCl 2 , 0 003% gelatin) 0 4 μL - Taq polymerase (5 U/μL), 1 2 uL - Taq dilution buffer ( 10 mM tris @ pH 8 0 and 1 0% Tween 20), 0 66 uL - each pπmer ( 10 μM), and I 0 uL - genomic DNA @ 50 ng/μL Heat to 94 °C for 2 min Thirty-five cycles of the following temperature profile were run 15"@ 94 °C, 2' at the specified annealing temperature and 1' @ 72 °C At the conclusion of cycling the reaction was incubated at 72 °C for 7 min. Visualization of amplification products is the same as described above Table 6 shows a comparison of the onset of false positive responses as the annealing temperature is reduced. TABLE 6 Percent False Positive L. monocytogenes Responses as a Function of Annealing Temperature Annealing Temperature, C. Primer Sets 70° 65° 60° 55° 1515-27-357/ 1515(8S.8S)-27-rc737 0% 0% 5% ND 1515-27-357/ 1515(85.85 )-28-rc793 0% 0% 55% ND 1515-26-36/ 1515-26-rc233 0% 5% 27% ND 1515(rc341,rc341)-27-(-281)/ 1515-26-rc233 0% 0% 0% 1.5% 1515(rc341,rc341)-26-(-363)/ 1515-26-rc233 0% 0% 0% 33% * Pπmer label numbers contained in parentheses, i.e., (85, 85) and (rc341, rc341), indicate that these primers were derived from fragments generated by the single primers, 1515-26-85 and 1515-26-rc341. Primer pairs that produced no false positives at 5 °C below the standard annealing temperature of 70 °C were considered as candidates for a PCR-based L. monocytogenes assay. Of all the primer sets tested, only 1515-26-36/ 1515-26-rc233 showed an unacceptable onset of false positive responses at 65 °C. Figures 4A-4C are gels illustrating the appearance of anomalous amplification products as the annealing temperature was reduced for the 1515-26-36/ 1515-26-rc233 primer pair The gel lanes are identified as follows in Table 7. TABLE Lone Strain Lane Strain 1 L. seeligen #2874 17 L. innocua #3429 B BLANK 18 L. ivanovii #3357 1 L. innocua #2921 1 L. welshimen #3558 3 L. ivanovii #3072 20 L. innocua #3571 4 L. innocua #3241 21 L. innocua #3797 5 L. innocua #3244 22 L. seeligeri #3828 6 L. seeligeri #3327 23 L. innocua #4094 7 L. ivanovii #3340 24 L. innocua #4101 8 L. innocua #3352 25 L. innocua #4323 9 L. welshimeri #3354 B BLANK 10 L. grayi #3356 26 L. seeligeri #4333 11 L. welshimeri #3359 27 L. innocua #4442 12 L. seeligeri #3371 28 L. innocua #4450 13 L. seeligeri #3374 29 L. innocua #4452 B BLANK 30 L. innocua #4463 14 L. welshimeri #3411 31 L. monocytogenes #3847 15 L. welshimeri #3412 32 L. monocytogenes #4324 16 L. innocua #3420 33 L. monocytogenes #4341 EXAMPLE 5 FINAL EVALUATION OF LISTERIA MONOCYTOGENES DIAGNOSTIC PRIMERS Example 5 illustrates the inclusiveness of the identified Listeria monocytogenes diagnostic primers for all strains of Listeria monocytogenes. The accuracy of all candidate primer sets was evaluated for a larger group of L. monocytogenes strains. A set of 323 strains of . monocytogenes was used to evaluate the inclusivity of a set of three primer sets. PCR assay conditions were the same as those specified above except that only a 70 °C annealing temperature was used. In PCR-based assays using these three primer sets, the accuracy was as follows: 1) 1515-27-357/1515(8585)-27-rc737, 100%; 2) 1515-27-357/1515(8585)-28-rc793, 99 2%; and 3) 1515(rc341x2)-26-363/1515-26-rc233, 99 5%. Although primer -281/rc233 was not tested, its inclusivity response was expected to be comparable to 1515(rc341x2)-26-363/1515-26-rc233. None of the three primer sets generated amplification products for the 30 non-monocytogenes strains in the annealing stπngency test panel Examples of the positive and negative test panel results for the 1515-27-357/15 15(8585)-27-rc737 primer pair are shown in Figures 5 A and 5B respectively Figures 5 A and 5B each show a gel analysis which corresponds to the strains listed in Table 8 TABLE 8 Positive test panel response for PCR Negative test panel response for PCR products generated from pnmer set products generated from pπmer set 1515-27- l515-27-357/1515(8585)-27-rc737 357/1515 (8585)-27-rc737 Lane Strain Lane Strain 1 L. monocytogenes #652 1 L. seeligen #2874 2 L. monocytogenes #1049 B BLANK 3 L. monocytogenes #936 2 L. innocua #2921 4 L. monocytogenes #954 3 L. ivanovii #3072 5 L. monocytogenes #957 4 L. innocua #3241 6 L. monocytogenes #952 5 L. innocua #3244 7 L. monocytogenes #946 6 L. seeligeri #3327 8 L. monocytogenes #955 7 L. ivanovii #3340 9 L. monocytogenes #937 8 L. innocua #3352 B BLANK 9 L. welshimeri #3354 10 L. monocytogenes #1051 10 L. grayi #3356 11 L. monocytogenes #1046 11 L. welshimeri #3359 12 L. monocytogenes #1067 12 L. seeligeri #3371 13 L. monocytogenes #1055 13 L. seeligeri #3374 14 L. monocytogenes #1057 B BLANK 15 L. monocytogenes #1087 14 L. welshimeri #3411 16 L. monocytogenes #1145 15 L. welshimeri #3412 17 L. monocytogenes #1146 16 L. innocua #3420 18 L. monocytogenes #1153 17 L. innocua #3429 B BLANK 18 L. ivanovii #3357 19 L. monocytogenes #1144 19 L. welshimen #3558 20 L. monocytogenes #1322 20 L. innocua #3571 21 L. monocytogenes #1287 21 L. innocua #3797 22 L. monocytogenes #1316 22 L. seeligeri #3828 23 L. monocytogenes #1306 23 L. innocua #4094 24 L. monocytogenes #1298 24 L. innocua #4101 25 L. monocytogenes #1302 25 L. innocua #4323 26 L. monocytogenes #1285 B BLANK 27 L. monocytogenes #1286 26 L. seeligen #4333 B BLANK 27 L. innocua #4442 28 L. monocytogenes #1294 28 L. innocua #4450 29 L. monocytogenes #1283 29 L. innocua #4452 30 L. monocytogenes #1288 30 L. innocua #4463 1 L. monocytogenes #1284 3 1 L. monocytogenes #3847 32 L. monocytogenes #1282 32 L. monocytogenes #4324 33 L. monocytogenes #1464 L. monocytogenes #4341 EXAMPLE 6 SELECTIVITY TESTING FOR LISTERIA SPP DIAGNOSTIC PRIMERS Selection of Listeria spp. Diagnostic Primers A comparison of sequence data for the five Listeria species made it possible to identify priming sites that were at least 90% homologous to L. monocytogenes. The following priming sites were selected as possible candidates: 76, 88, 624, rc483, rc555, rc573, and rc324. Primers to these sites were made 30 bases in length to compensate for mismatches in sequence and to assure that a 70 °C annealing temperature could be maintained. Figure 6 shows the primer sequences and a comparison of priming site sequences for strains representing the following species: L. monocytogenes, L. innocua, L. seeligeri, L. welshimeri and L. ivanovii. Primer pairs from this group were first evaluated with a 33 -strain test panel consisting of 15 L. innocua, 5 L. welshimeri, 6 L. seeligeri, 3 L. ivanovii, 1 L. grayi and 3 L. monocytogenes. Amplifications were first carried out at an annealing temperature of 70 °C. The results of this evaluation are summarized in Table 9. TABLE 9 % Positive Response for PCR-Based Assay ofL. spp. : Effect of Priming Site Location Priming Sites: 76 88 624 rc483 80% 85% Not Applicable rc555 100% 100% Not Applicable rc573 100% 100% Not Applicable r rcc882244 0% N Noott D Deetteerrnmined 0% The 76, 88, rc555 and rc573 priming sites all appear to be viable at a 70 °C annealing temperature, based on the 100% positive response that is achieved with any combination of these primers. When rc483 is used in conjunction with 76 or 88 the positive response drops off to the 80-85%ι response range. Decreasing the annealing temperature to 65 °C increases the response to 97%. Although both 76/rc824 and 624/rc824 generated no PCR product with a 70 °C annealing temperature, when the temperature was decreased to 65 °C the positive response increased to 97% In all of the tests at 65 °C the only false negative was a single L grayi strain It appears that the melting temperatures of the rc824 and rc483 primers are too low to permit their effective use at a 70 °C No further testing was done with these pπmers The 76, 88, rc555 and rc573 priming sites all appear to be viable at a 70 °C annealing temperature L. grayi and L. murrayi are not as frequently encountered as other L. spp However, since no sequence data was determined for these species, additional strains were tested with the primer sets that scored 100%) The test group consisted of 7 strains ofL. grayi and 4 strains ofL. murrayi The positive response of the various primer sets was as follows 76/rc555 50%, 76/rc573 18%, 88/rc555 27%, and 88/rc573 9% The weak and variable response ofL. grayi and L. murrayi to the genus level priming sites is not surprising. DNA-DNA hybridization studies have shown that L. grayi and L. murrayi were only moderately related to reference strains of L. monocytogenes, L. innocua, L. seeligeri, L. welshimeri and L. ivanovii, i.e., at 3-29% and 1-9% respectively (Rocourt et al., Curr. Microbiol. 7.383-388 (1982).) Based on this and other DNA-DNA hybridization studies, it has been suggested that L. grayi and L. murrayi are sufficiently different from L. monocytogenes to merit their separation into a new genus, Murraya grayi. The issue of how these species should be classified is currently undecided. Regardless of how strains from these two species are ultimately classified, the genus level primers show a generally weak positive response to strains from this group. The strength of the positive response is expected to be extremely dependent on the level of DNA used in the assay with sensitivity to L. grayi and L. murrayi strains expected to run 3 orders of magnitude poorer than other Listeria species EXAMPLE 7 SELECTION OF LISTERIA SPP. DIAGNOSTIC PRIMERS ON THE BASIS OF SENSITIVITY TO ANNEALING TEMPERATURE To minimize the likelihood that L. spp. primers would generate PCR products from mismatched priming in non-Listeria strains, the relationship between annealing temperature and amplification specificity was evaluated. Amplifications were carried out on a test panel of 7 strains at an annealing temperature of 70 °C Annealing temperature was then decreased in 5 °C increments until the onset of nonspecific amplification products The primer combinations of 76/rc573 and 88/rc573 both showed nonspecific products at 65 °C At 60 °C 88/rc555 began to show nonspecific products Such products were not observed for the 76/rc555 primer set until the annealing temperature was reduced to 55 °C Since the 76/rc555 primer set was least likely to generate nonspecific amplification products this pπmer set was the primary candidate for the Listeria spp. detection assay EXAMPLE 8 FINAL EVALUATION OF LISTERIA SPP. DIAGNOSTIC PRIMERS Final Evaluation of Listeria spp. Candidate Primer Set Before the 76/rc555 primer selection was confirmed, the accuracy of this set was evaluated for additional L. spp. strains. This entire test panel consisted of 73 strains that were broken down by species as follows: 9 L. monocytogenes, 34 L. innocua, 5 L. welshimeri, 11 L. seeligeri, 3 L. ivanovii, 7 L. grayi and 4 L. murrayi. PCR conditions were the same as those specified above except that only a 70 °C annealing temperature was used. All of the strains belonging to the species L. monocytogenes, L. innocua, L. welshimeri, L. seeligeri, and L. ivanovii, tested at 100% positive for the 76/rc555 primer set. As reported above, the test group of 7 L. grayi and 4 L. murrayi strains scored at 50%. The accuracy of the 76/rc555 primer set was also evaluated on a non- Listeria spp. test panel consisting of 65 strains that represent a variety of related gram positive strains and enteric gram negative strains. The species tested are summarized in Table 10. TABLE 10 Negative Test Panel for Screening of Listeria spp. Primer Set 1515-30-76/1515(8585)-30-rc555 Species No. of Strains Species No. of Strains Aeromonas species 1 Salmonella enteritidis 3 Bacillus cereus 4 Salmonella redlands 1 Bacillus subtilis 2 Salmonella virchow 1 Bacillus thuringiensis 3 Salmonella Santiago 2 Carnobacterium piscicola 2 Staphylococcus aureus 4 Enterococcus casseliflavus 1 Staphylococcus camosus 2 Enterococcus faecalis 10 Staphylococcus epidermidis 6 Enterococcus faecium 1 Staphylococcus species 1 Enterococcus species 1 Staphylococcus wameri 2 Escherichia coli 2 Staphylococcus xylosus 1 Lactococcus lactis 9 Brochothrix thermosphacta 8 None of the strains in Table 10 produced a positive PCR response for annealing temperatures ranging from 60-70 °C. Examples of the results of Listeria spp. and non-Listeria spp. test panels for the 76/rc555 primer pair are shown by gel analysis in Figures 7A and 7B respectively. The lanes are identified as follows in Table 1 1 TABLE 11 Listeria spp. positive test panel response for PCR products generated from primer set 1515-30-76/1515(8585)-30-rc555 corresponding to Figure 4 Lane Strain Lane Strain 1 L. seeligeri #2874 17 L. innocua #3429 B BLANK 18 L. ivanovii #3357 2 L. innocua #2921 19 L. welshimeri #3558 3 L. ivanovii #3072 20 L. innocua #3571 4 L. innocua #3241 21 L. innocua #3797 5 L. innocua #3244 22 L. seeligeri #3828 6 L. seeligeri #3327 23 L. innocua #4094 7 L. ivanovii #3340 24 L. innocua #4101 8 L. innocua #3352 25 L. innocua #4323 9 L. welshimeri #3354 B BLANK 10 L. grayi #3356 26 L. seeligeri #4333 11 L. welshimeri #3359 27 L. innocua #4442 12 L. seeligeri #3371 28 L. innocua #4450 13 L. seeligeri #3374 29 L. innocua #4452 B BLANK 30 L. innocua #4463 14 L. welshimeri #3411 31 L. monocytogenes #3847 15 L. welshimeri #3412 32 L. monocytogenes #4324 16 L. innocua #3420 33 L. monocytogenes #4341 TABLE 12 Listeria spp. negative test panel response for PCR products generated from pπmer set 1515-30-76/1515(8585)-3()-rc555 Lane Strain Lane Strain 1 Escherichia coli #642 23 Lactococcus lactis #3587 1 Staphylococcus epidermidis #764 24 Lactococcus lactis #3588 3 Staphylococcus epidermidis #783 25 Lactococcus lactis #3589 4 Staphylococcus aureus #789 26 Lactococcus lactis #3590 5 Staphylococcus epidermidis #796 27 Lactococcus lactis #3591 6 Staphylococcus warneri #797 28 Escherichia coli #3803 7 Staphylococcus warneri #799 29 Lactococcus lactis #3817 8 Staphylococcus aureus #895 30 Aeromonas species #3818 9 Camobacterium piscicola #920 BLANK 10 Staphylococcus aureus #923 31 Enterococcus faecalis #3837 BLANK 32 Enterococcus faecalis #3838 11 Bacillus subtilis #1011 33 Enterococcus species #4095 12 Bacillus subtilis #1041 34 Enterococcus faecium #4428 13 Staphylococcus camosus #1090 35 Salmonella redlands #4563 14 Staphylococcus camosus #1091 36 Salmonella enteritidis #4565 15 Staphylococcus xylosus #1120 37 Salmonella enteritidis #4593 16 Camobacterium piscicola #1160 38 Bacillus thuringiensis #4941 17 Bacillus thuringiensis #1221 39 Bacillus thuringiensis #5083 18 Staphylococcus aureus #2095 40 Enterococcus faecalis #5504 19 Enterococcus faecalis #3074 41 Salmonella virchow #5508 20 Lactococcus lactis #3584 42 Enterococcus casseliflavus #5574 BLANK BLANK 21 Lactococcus lactis #3585 43 Listeria monocytogenes #3844 22 Lactococcus lactis #3586 44 Listeria monocytogenes #3278 SEQUENCE LISTING (1) GENERAL INFORMATION: (i) APPLICANT: HAZEL, JAMES WILLIAM JENSEN, MARK ANTON (ll) TITLE GF INVENTION: GENETIC MARKERS AND METHODS FOR THE DETECTION OF LISTERIA MONOCYTOGENES AND LISTERIA SPP . (iii) NUMBER OF SEQUENCES: 110 (iv) CORRESPONDENCE ADDRESS: (A) ADDRESSEE: E. I. DU PONT DE NEMOURS AND COMPANY (B) STREET: 1007 MARKET STREET (C) CITY: WILMINGTON (D) STATE: DELAWARE (E) COUNTRY: U.S.A. (F) ZIP: 19898 (v) COMPUTER READABLE FORM: (A) MEDIUM TYPE: 3.50 INCH DISKETTE (B) COMPUTER: IBM PC COMPATIBLE (C) OPERATING SYSTEM: MICROSOFT WINDOWS 3.1 (D) SOFTWARE: MICROSOFT WORD 2.0C (vi) CURRENT APPLICATION DATA: (A) APPLICATION NUMBER: (B) FILING DATE: (C) CLASSIFICATION: (vii) PRIOR APPALICATION DATA: (A) APPLICATION NUMBER: 08/745,228 (B) FILING DATE: NOVEMBER 8, 1996 (viii) ATTORNEY/AGENT INFORMATION: (A) NAME: FLOYD, LINDA AXAMETHY (B) REGISTRATION NO. : 33,692 (C) REFERENCE/DOCKET NUMBER: MD-1065-A (ix) TELECOMMUNICATION INFORMATION: (A) TELEPHONE: 302-892-8112 (B) TELEFAX: 302-773-0164 , INFORMATION FOR SEQ ID NO : 1 : ( ) SEQUENCE CHARACTERISTICS: (Al LENGTH: 12 base pairs (B) TYPE: nucleic acid ;C> STRANDEDNESS: single ,'D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:l: AGCTGATGCT AC 12 (2) INFORMATION FOR SEQ ID NO : 2 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 12 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:2: AGTCGAACTG TC 12 (2) INFORMATION FOR SEQ ID NO: 3: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 12 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 3: TTAGTCACGG CA 12 (2) INFORMATION FOR SEQ ID NO: 4: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 12 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 4: TGCGATACCG TA 2 (2) INFORMATION FOR SEQ ID NO: 5: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 12 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear MOLECULE TYPE. DNA i enomic) .< l ) SEQUENCE DESCRIPTION: SEQ ID NO: 5: CTACAGCTGA TG 12 (2) INFORMATION FOR SEQ ID NO : 6 : ( 1 ) SEQUENCE CHARACTERISTICS: (A) LENGTH: 12 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (l l ) MOLECULE TYPE: DNA (genomic) ( XI ) SEQUENCE DESCRIPTION: SEQ ID NO: 6: GTCAGTCGAA CT 2 (2) INFORMATION FOR SEQ ID NO: 7: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 12 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 7: GGCATTAGTC AC 12 (2) INFORMATION FOR SEQ ID NO: 8: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 12 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (Xi) SEQUENCE DESCRIPTION: SEQ ID NO: 8: CGTATGCGAT AC 12 (2) INFORMATION FOR SEQ ID NO: 9: ( 1 ) SEQUENCE CHARACTERISTICS: (A) LENGTH: 12 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:9: AACCTCGTGT AG 12 ;21 INFORMATION FOR SEQ ID MO: 10: ! ) SEQUENCE CHARACTERISTICS: (A) LENGTH: 12 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 10: CATTCGGGTA CA 12 (2) INFORMATION FOR SEQ ID NO: 11: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 12 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:ll: GCCCTTAGTG AA 12 (2) INFORMATION FOR SEQ ID NO: 12: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 12 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 12: GCAGTTATGA CC 12 (2) INFORMATION FOR SEQ ID NO: 13: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 12 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 13: CCAGCTATCT CT 12 (2) INFORMATION FOR SEQ ID NO: 14: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 12 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear :n) MOLECULE TYPE: DNA (genomic) (x ) SEQUENCE DESCRIPTION: SEQ ID NO: 14: AGAAGGCAGT TG 12 (2) INFORMATION FOR SEQ ID NO: 15: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 12 base pairs j3) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 15: GGACAGAGCA TA 12 (2) INFORMATION FOR SEQ ID NO: 16: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 12 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 16: CGTTTCGCTT CA 12 (2) INFORMATION FOR SEQ ID NO: 17: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 27 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO.-17: TGCTGTTTGG TTTGCTCTAG CCCAGTG 27 (2) INFORMATION FOR SEQ ID NO: 18: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 27 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) ( X i) SEQUENCE DESCRIPTION: SEQ ID NO: 18: CAACTTTCCA CATGGCGCGA TTATTTG 27 , 2 ; I NFORMAT ION FOR S EQ I D MO : 19 : < ) S EQUENCE CHARACTERI STI CS : ( A) LENGTH : 26 bas e pai rs ( B ) TYPE : nucleic acid ( C ) STRANDEDNES S : s ingle ( D ) TOPOLOGY : li nea r (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 19: GGGGAACTGC CGAAGATCGT ACAGCA 26 (2) INFORMATION FOR SEQ ID NO:20: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 414 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (vi) ORIGINAL SOURCE: (B) STRAIN: L MONO - 647 - PREMARKER (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 20: GGACAGAGCA TAGTTGGATG GAAACAATCC GATCAGCGGG AACGTTTTTG ATAGATTCTG 60 CTGTTTGGTT TGCTCTAGCC CAGTGCCACG TGTCACAAAT AAGTTGCGCA TTATCTCGGC 120 CGCATGCTTC TGCTACTCGC CAAGCTGCTT GTAAGTCTGC TACACCGCTA TATGGCATAA 180 ATTCTAAACC AATAATTAAT TCTTCTGCGC GGTCACATAA TTCACCAAGC GCGACGATGA 240 TTTGTTCCTC AGGGATTTTT TCAAGCAAAC CACAATTAAT ATGTTTGACG CCAAATAATC 300 GCGCCATGTG GAAAGTTGTT TGCTCTTTCT TTTGTTGTTC TGCTGTACGA TCTTCGGCAG 360 TTCCCCACTG AGTTATGTAC TCCACTTCTG TTACTTTCAT GTTATGCTCT GTCC 414 (2) INFORMATION FOR SEQ ID NO: 21: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 414 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iv) ANTI-SENSE: YES (vi) ORIGINAL SOURCE: (B) STRAIN: L MONO - 647 - PREMARKER (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 21: GGACAGAGCA TAACATGAAA GTAACAGAAG TGGAGTACAT AACTCAGTGG GGAACTGCCG 60 AAGATCGTAC AGCAGAACAA CAAAAGAAAG AGCAAACAAC TTTCCACATG GCGCGATTAT 120 TTGGCGTCAA ACATATT.AAT TGTGGTTTGC TTGAAAAAAT CCCTGAGGAA CAAA CATCG - 3 TCGCGCTTGG TGAATTATGT GACCGCGCAG AAGAATTAAT TATTGGTTTA GAATTTATGC 2 0 CATATAGCGG TGTAGCAGAC TTACAAGCAG CTTGGCGAGT AGCAGAAGCA TGCGGCCGAG 300 ATAATGCGCA ACTTATTTGT GACACGTGGC ACTGGGCTAG AGCAAACCAA ACAGCAGAAT 360 CTATCAAAAA CGTTCCCGCT GATCGGATTG TTTCCATCCA ACTATGCTCT GTCC 14 (2) INFORMATION FOR SEQ ID NO: 22: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 414 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (vi) ORIGINAL SOURCE: (A) ORGANISM: L MONO - 1324 - PREMARKER (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 22: GGACAGAGCA TAGTTGGATA GAAACAATCC GATCAGCGGG AACATTTTTG ATAGATTCAG 60 CTGTTTGATT TGCTCTAGCC CAGTGCCATG TGTCACAAAT AAGTTGCGCG TTATCTCGTC 120 CGCATGCTTC TGCTACTCGC CAAGCTGCTT GTAAGTCTGC TACACCGCTA TATGGCATAA 180 ATTCTAAACC AATAATTAAT TCTTCTGCGC GGTCACATAA TTCACCAAGC GCGACAATGA 240 TTTGTTCCTC AGGGATTTTT TCAAGCAAAC CACAATTAAT ATGTTTGACG CCAAATAATC 300 GCGCCATGTG GAAAGTTGTT TGCTCTTTCT TTTGTTGTTC TGCTGTACGA TCTTCGGCAG 360 TTCCCCACTG GGTTATGTAC TCCACTTCTG TTACTTTCAT GTTATGCTCT GTCC 414 (2) INFORMATION FOR SEQ ID NO:23: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 414 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iv) ANTI-SENSE: YES (vi) ORIGINAL SOURCE: (B) STRAIN: L MONO - 1324 - PREMARKER (xi) SEQUENCE DESCRIPTION: SEQ ID NO:23: GGACAGAGCA TAACATGAAA GTAACAGAAG TGGAGTACAT AACCCAGTGG GGAACTGCCG 60 AAGATCGTAC AGCAGAACAA CAAAAGAAAG AGCAAACAAC TTTCCACATG GCGCGATTAT 120 TTGGCGTCAA ACATATTAAT TGTGGTTTGC TTGAAAAAAT CCCTGAGGAA CAAATCATTG 180 TCGCGCTTGG TGAATTATGT GACCGCGCAG AAGAATTAAT TATTGGTTTA GAATTTATGC 240 :ATA AGCGG GTAGCAGAC TACAAGCAG CTTGGCGAGT AGCAGAAGCA TGCGGACGAG 300 ATAACGCGCA ACTTATTTGT GACACATGGC ACTGGGCTAG AGCAAATCAA ACAGCTGAAT 360 CTATCAAAAA TGTTCCCGCT GATCGGATTG TTTCTATCCA ACTATGCTCT GTCC 414 i 2 INFORMATION FOR SEQ ID MO: 24: ' ) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1354 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (vi) ORIGINAL SOURCE: (B) STRAIN: L MONO - 647 - D. FRAG (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 24: TAAGCAAGGA AGTATCTGAT AAAGTCCATC TGTATTTGCA TAGTTGTTAC ACATTGGCGA 60 TACGACAAAT CTGTTAGGCA CCTTCATCGG CCCGATATCA ATAGGTGAAA ACATCGAATT 120 AAATTTCAAA AATAACACAT TCCTTTCACA GGGAGTCTTC CTACTACGTT ATTATTTTCA 180 CATAAGCGAG TAGGTGTTTA GCGTGGAGAA ATTTCTGGCC ATGCTTCGTC TAATACTTTT 240 TTCGTGGCAT TGTATACTTT AAGGGCGGCA TACTCTAAAC CAGTTGCTAC CATAGAGTCT 300 GAAATAACTT CGACTCCCAT CACACGTGGA TTTACACCAT GTTCTTTTAA AATTTTTGCA 360 AAACCGACCG TATCTCCGTA GCCTTCTCCA GGAGCTAGAC GATCATGAAG TGATTCCTCA 420 CGAAGTTCTT TGTAAGGCGT TTCGTGGACA TCGCATAGTT GGATGGAAAC AATCCGATCA 480 GCGGGAACGT TTTTGATAGA TTCTGCTGTT TGGTTTGCTC TAGCCCAGTG CCACGTGTCA 540 CAAATAAGTT GCGCATTATC TCGGCCGCAT GCTTCTGCTA CTCGCCAAGC TGCTTGTAAG 600 TCTGCTACAC CGCTATATGG CATAAATTCT AAACCAATAA TTAATTCTTC TGCGCGGTCA 660 CATAATTCAC CAAGCGCGAC GATGATTTGT TCCTCAGGGA TTTTTTCAAG CAAACCACAA 720 TTAATATGTT TGACGCCAAA TAATCGCGCC ATGTGGAAAG TTGTTTGCTC TTTCTTTTGT 780 TGTTCTGCTG TACGATCTTC GGCAGTTCCC CACTGAGTTA TGTACTCCAC TTCTGTTACT 840 TTCATGTTAT GCTCGTCTAA AATCCGCAAC ATGTCTTCAT CCGTTAATCC GGCAGCTAGT 900 GCATCTACAT AGTTTTCTGC ACGCAAGCCA ATTCCGTCAA AACCGTTTTC CGCAGCGACT 960 TTTACTCGTT TAGGAAAAGA TACCTCTGTT CCAAGCGTAT AAGAGCTAAT CGTGATGGGG 1020 CATTTTTTTA GGTTGCCATT TGCATTTGTC ATAAAAATTA TCTCCTCTCC ATAATAAAAA 1080 TTACAAGAAA CTTTGATAAT ATTTTCACAA ACACCAGTAA AAAAATTAAT TCCGCTTAAT 1140 TAAAAACCTC TGATGTGATA ACGCCTTCAA TAGTTGAAAA TGGAACTGGA CAGTTAACCT 1200 ATTCTACCGT ATATTGGTTT TTAAGGAATA GTTTATTTCA CTGGCGTAAC TACAGTCTAA 1260 TTGTATTATG ACTATTCCAT AAAAACAAAT TGGTATTGTT CTATTAATTG ATAGATAAAT 1320 TGCATAGATA ACTTTTTAGT TAGGAGAGAA GCAT -354 (2) INFORMATION FOR SEQ ID NO: 25: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1354 base pairs (3) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (i ) MOLECULE TYPE: DNA (genomic) (iv) ANTI-SENSE: YES (vi) ORIGINAL SOURCE: (B) STRAIN: L MONO 647 - D.F. (Xi) SEQUENCE DESCRIPTION: SEQ ID NO:25: ATGCTTCTCT CCTAACTAAA AAGTTATCTA TGCAATTTAT CTATCAATTA ATAGAACAAT 60 ACCAATTTGT TTTTATGGAA TAGTCATAAT ACAATTAGAC TGTAGTTACG CCAGTGAAAT 120 AAACTATTCC TTAAAAACCA ATATACGGTA GAATAGGTTA ACTGTCCAGT TCCATTTTCA 180 ACTATTGAAG GCGTTATCAC ATCAGAGGTT TTTAATTAAG CGGAATTAAT TTTTTTACTG 240 GTGTTTGTGA AAATATTATC AAAGTTTCTT GTAATTTTTA TTATGGAGAG GAGATAATTT 300 TTATGACAAA TGCAAATGGC AACCTAAAAA AATGCCCCAT CACGATTAGC TCTTATACGC 360 TTGGAACAGA GGTATCTTTT CCTAAACGAG TAAAAGTCGC TGCGGAAAAC GGTTTTGACG 420 GAATTGGCTT GCGTGCAGAA AACTATGTAG ATGCACTAGC TGCCGGATTA ACGGATGAAG 480 ACATGTTGCG GATTTTAGAC GAGCATAACA TGAAAGTAAC AGAAGTGGAG TACATAACTC 540 AGTGGGGAAC TGCCGAAGAT CGTACAGCAG AACAACAAAA GAAAGAGCAA ACAACTTTCC 600 ACATGGCGCG ATTATTTGGC GTCAAACATA TTAATTGTGG TTTGCTTGAA AAAATCCCTG 660 AGGAACAAAT CATCGTCGCG CTTGGTGAAT TATGTGACCG CGCAGAAGAA TTAATTATTG 720 GTTTAGAATT TATGCCATAT AGCGGTGTAG CAGACTTACA AGCAGCTTGG CGAGTAGCAG 780 AAGCATGCGG CCGAGATAAT GCGCAACTTA TTTGTGACAC GTGGCACTGG GCTAGAGCAA 840 ACCAAACAGC AGAATCTATC AAAAACGTTC CCGCTGATCG GATTGTTTCC ATCCAACTAT 900 GCGATGTCCA CGAAACGCCT TACAAAGAAC TTCGTGAGGA ATCACTTCAT GATCGTCTAG 960 CTCCTGGAGA AGGCTACGGA GATACGGTCG GTTTTGCAAA AATTTTAAAA GAACATGGTG 1020 TAAATCCACG TGTGATGGGA GTCGAAGTTA TTTCAGACTC TATGGTAGCA ACTGGTTTAG 1080 AGTATGCCGC CCTTAAAGTA TACAATGCCA CGAAAAAAGT ATTAGACGAA GCATGGCCAG 1140 AAATTTCTCC ACGCTAAACA CCTACTCGCT TATGTGAAAA TAATAACGTA GTAGGAAGAC 1200 TCCCTGTGAA AGGAATGTGT TATTTTTGAA ATTTAATTCG ATGTTTTCAC CTATTGATAT 1260 CGGGCCGATG AAGGTGCCTA ACAGATTTGT CGTATCGCCA ATGTGTAACA ACTATGCAAA 1320 TACAGATGGA TTTATCAGA TACTTCCTTG CTTA 1354 ; INFORMATION FOR SEQ ID MO: 26: < ) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1327 base pairs (B) TYPE: nucleic acid 'O STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (vi) ORIGINAL SOURCE: (B) STRAIN: L MONO 899 D.F. (xi) SEQUENCE DESCRIPTION: SEQ ID NO:26: ATCTGTATTT GCATAGTTGT TACACATTGG CGATACGACA AATCTGTTAG GCACCTTCAT 60 CGGCCCGATA TCAATAGGTG AAAACATCGA ATTAAATTTC AAAAATAACA CATTCCTTTC 120 ACAGGGAGTC TTCCTACTAC GTTATTATTT TCACATAAGC GAGTAGGTGT TTAGCGTGGA 180 GAAATTTCTG GCCATGCTTC GTCTAATACT TTTTTCGTGG CATTGTATAC TTTAAGGGCG 240 GCATACTCTA AACCAGTTGC TACCATAGAG TCTGAAATAA CTTCGACTCC CATCACACGT 300 GGATTTACAC CATGTTCTTT TAAAATTTTT GCAAAACCGA CCGTATCTCC GTAGCCTTCT 360 CCAGGAGCTA GACGATCATG AAGTGATTCC TCACGAAGTT CTTTGTAAGG CGTTTCGTGG 420 ACATCGCATA GTTGGATGGA AACAATCCGA TCAGCGGGAA CGTTTTTGAT AGATTCTGCT 480 GTTTGGTTTG CTCTAGCCCA GTGCCACGTG TCACAAATAA GTTGCGCATT ATCTCGGCCG 540 CATGCTTCTG CTACTCGCCA AGCTGCTTGT AAGTCTGCTA CACCGCTATA TGGCATAAAT 600 TCTAAACCAA TAATTAATTC TTCTGCGCGG TCACATAATT CACCAAGCGC GACGATGATT 660 TGTTCCTCAG GGATTTTTTC AAGCAAACCA CAATTAATAT GTTTGACGCC AAATAATCGC 720 GCCATGTGGA AAGTTGTTTG CTCTTTCTTT TGTTGTTCTG CTGTACGATC TTCGGCAGTT 780 CCCCACTGAG TTATGTACTC CACTTCTGTT ACTTTCATGT TATGCTCGTC TAAAATCCGC 840 AACATGTCTT CATCCGTTAA TCCGGCAGCT AGTGCATCTA CATAGTTTTC TGCACGCAAG 900 CCAATTCCGT CAAAACCGTT TTCCGCAGCG ACTTTTACTC GTTTAGGAAA AGATACCTCT 960 GTTCCAAGCG TATAAGAGCT AATCGTGATG GGGCATTTTT TTAGGTTGCC ATTTGCATTT 1020 GTCATAAAAA TTATCTCCTC TCCATAATAA AAATTACAAG AAACTTTGAT AATATTTTCA 1080 CAAACACCAG TAAAAAAATT AATTCCGCTT AATTAAAAAC CTCTGATGTG ATAACGCCTT 1140 CAATAGTTGA AAATGGAACT GGACAGTTAA CCTATTCTAC CGTATATTGG TTTTTAAGGA 1200 ATAGTTTATT TCACTGGCGT AACTACAGTC TAATTGTATT ATGACTATTC CATAAAAACA 1260 AATTGGTATT GTTCTATTAA TTGATAGATA AATTGCATAG ATAACTTTTT AGTTAGGAGA 1320 GAAGCAT 1327 Z I N FORMAT I ON FOR S EQ I D NC : 2 " \ ' I ' S EQUENCE CHARACTERI ST ICS : (A ) LENGTH : 1327 bas e pai rs ( 3 ) TYPE : nucl ei c a cid ( C ) STRANDEDNES S : s ingle ( D ) TOPOLOGY : l inea r (ii) MOLECULE TYPE: DNA (genomic (iv) ANTI-SENSE: YES (vi) ORIGINAL SOURCE: (B) STRAIN: L MONO 899 D.F. (XI) SEQUENCE DESCRIPTION: SEQ ID NO:27: ATGCTTCTCT CCTAACTAAA AAGTTATCTA TGCAATTTAT CTATCAATTA ATAGAACAAT 60 ACCAATTTGT TTTTATGGAA TAGTCATAAT ACAATTAGAC TGTAGTTACG CCAGTGAAAT 120 AAACTATTCC TTAAAAACCA ATATACGGTA GAATAGGTTA ACTGTCCAGT TCCATTTTCA 180 ACTATTGAAG GCGTTATCAC ATCAGAGGTT TTTAATTAAG CGGAATTAAT TTTTTTACTG 240 GTGTTTGTGA AAATATTATC AAAGTTTCTT GTAATTTTTA TTATGGAGAG GAGATAATTT 300 TTATGACAAA TGCAAATGGC AACCTAAAAA AATGCCCCAT CACGATTAGC TCTTATACGC 360 TTGGAACAGA GGTATCTTTT CCTAAACGAG TAAAAGTCGC TGCGGAAAAC GGTTTTGACG 420 GAATTGGCTT GCGTGCAGAA AACTATGTAG ATGCACTAGC TGCCGGATTA ACGGATGAAG 480 ACATGTTGCG GATTTTAGAC GAGCATAACA TGAAAGTAAC AGAAGTGGAG TACATAACTC 540 AGTGGGGAAC TGCCGAAGAT CGTACAGCAG AACAACAAAA GAAAGAGCAA ACAACTTTCC 600 ACATGGCGCG ATTATTTGGC GTCAAACATA TTAATTGTGG TTTGCTTGAA AAAATCCCTG 660 AGGAACAAAT CATCGTCGCG CTTGGTGAAT TATGTGACCG CGCAGAAGAA TTAATTATTG 720 GTTTAGAATT TATGCCATAT AGCGGTGTAG CAGACTTACA AGCAGCTTGG CGAGTAGCAG 780 AAGCATGCGG CCGAGATAAT GCGCAACTTA TTTGTGACAC GTGGCACTGG GCTAGAGCAA 840 ACCAAACAGC AGAATCTATC AAAAACGTTC CCGCTGATCG GATTGTTTCC ATCCAACTAT 900 GCGATGTCCA CGAAACGCCT TACAAAGAAC TTCGTGAGGA ATCACTTCAT GATCGTCTAG 960 CTCCTGGAGA AGGCTACGGA GATACGGTCG GTTTTGCAAA AATTTTAAAA GAACATGGTG 1020 TAAATCCACG TGTGATGGGA GTCGAAGTTA TTTCAGACTC TATGGTAGCA ACTGGTTTAG 1080 AGTATGCCGC CCTTAAAGTA TACAATGCCA CGAAAAAAGT ATTAGACGAA GCATGGCCAG 1140 AAATTTCTCC ACGCTAAACA CCTACTCGCT TATGTGAAAA TAATAACGTA GTAGGAAGAC 1200 TCCCTGTGAA AGGAATGTGT TATTTTTGAA ATTTAATTCG ATGTTTTCAC CTATTGATAT 1260 CGGGCCGATG AAGGTGCCTA ACAGATTTGT CGTATCGCCA ATGTGTAACA ACTATGCAAA 1320 TACAGAT 1327 2 INFORMAT I ON FOR S EQ I D MO : 23 : ' i S EQUENCE CHARACTERI STI CS : (A ) LENGTH : 1274 bas e pai rs ( B ) TYPE : nucl ei c acid ( C ) STRANDEDNESS : s ingle ( D ) TOPOLOGY : l i nea r in) MOLECULE TYPE: DNA (genomic) (vi) ORIGINAL SOURCE: (B) STRAIN: L MONO 3386 D.F. (xi) SEQUENCE DESCRIPTION: SEQ ID NO:28: AGGCACCTTC ATCGGCCCGA TATCAATAGG TGAAAACATC GAATTAAATT TCAAAAATAA 60 CACATTCCTT TCACAGGGAG TCTTCCTACT ACGTTATTAT TTTCACATAA GCGAGTAGGT 120 GTTTAGCGTG GAGAAATTTC TGGCCATGCT TCGTCTAATA CTTTTTTCGT GGCATTGTAT 180 ACTTTAAGGG CGGCATACTC TAAACCAGTT GCTACCATAG AGTCTGAAAT AACTTCGACT 240 CCCATCACAC GTGGATTTAC ACCATGTTCT TTTAAAATTT TTGCAAAACC GACCGTATCT 300 CCGTAGCCTT CTCCAGGAGC TAGACGATCA TGAAGTGATT CCTCACGAAG TTCTTTGTAA 360 GGCGTTTCGT GGACATCGCA TAGTTGGATG GAAACAATCC GATCAGCGGG AACGTTTTTG 420 ATAGATTCTG CTGTTTGGTT TGCTCTAGCC CAGTGCCACG TGTCACAAAT AAGTTGCGCA 480 TTATCTCGGC CGCATGCTTC TGCTACTCGC CAAGCTGCTT GTAAGTCTGC TACACCGCTA 540 TATGGCATAA ATTCTAAACC AATAATTAAT TCTTCTGCGC GGTCACATAA TTCACCAAGC 600 GCGACGATGA TTTGTTCCTC AGGGATTTTT TCAAGCAAAC CACAATTAAT ATGTTTGACG 660 CCAAATAATC GCGCCATGTG GAAAGTTGTT TGCTCTTTCT TTTGTTGTTC TGCTGTACGA 720 TCTTCGGCAG TTCCCCACTG AGTTATGTAC TCCACTTCTG TTACTTTCAT GTTATGCTCG 780 TCTAAAATCC GCAACATGTC TTCATCCGTT AATCCGGCAG CTAGTGCATC TACATAGTTT 840 TCTGCACGCA AGCCAATTCC GTCAAAACCG TTTTCCGCAG CGACTTTTAC TCGTTTAGGA 900 AAAGATACCT CTGTTCCAAG CGTATAAGAG CTAATCGTGA TGGGGCATTT TTTTAGGTTG 960 CCATTTGCAT TTGTCATAAA AATTATCTCC TCTCCATAAT AAAAATTACA AGAAACTTTG 1020 ATAATATTTT CACAAACACC AGTAAAAAAA TTAATTCCGC TTAATTAAAA ACCTCTGATG 1080 TGATAACGCC TTCAATAGTT GAAAATGGAA CTGGACAGTT AACCTATTCT ACCGTATATT 1140 GGTTTTTAAG GAATAGTTTA TTTCACTGGC GTAACTACAG TCTAATTGTA TTATGACTAT 1200 TCCATAAAAA CAAATTGGTA TTGTTCTATT AATTGATAGA TAAATTGCAT AGATAACTTT 1260 TTAGTTAGGA GAGA 1274 (2) INFORMATION FOR SEQ ID NO:29: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1274 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (11) MOLECULE TYPE: DNA (genomic) (iv) ANTI-SENSE: YES (vi) ORIGINAL SOURCE: (B) STRAIN: L MONO 3386 D.F (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 29: TCTCTCCTAA CTAAAAAGTT ATCTATGCAA TTTATCTATC AATTAATAGA ACAATACCAA 60 TTTGTTTTTA TGGAATAGTC ATAATACAAT TAGACTGTAG TTACGCCAGT GAAATAAACT 120 ATTCCTTAAA AACCAATATA CGGTAGAATA GGTTAACTGT CCAGTTCCAT TTTCAACTAT 180 TGAAGGCGTT ATCACATCAG AGGTTTTTAA TTAAGCGGAA TTAATTTTTT TACTGGTGTT 240 TGTGAAAATA TTATCAAAGT TTCTTGTAAT TTTTATTATG GAGAGGAGAT AATTTTTATG 300 ACAAATGCAA ATGGCAACCT AAAAAAATGC CCCATCACGA TTAGCTCTTA TACGCTTGGA 360 ACAGAGGTAT CTTTTCCTAA ACGAGTAAAA GTCGCTGCGG AAAACGGTTT TGACGGAATT 420 GGCTTGCGTG CAGAAAACTA TGTAGATGCA CTAGCTGCCG GATTAACGGA TGAAGACATG 480 TTGCGGATTT TAGACGAGCA TAACATGAAA GTAACAGAAG TGGAGTACAT AACTCAGTGG 540 GGAACTGCCG AAGATCGTAC AGCAGAACAA CAAAAGAAAG AGCAAACAAC TTTCCACATG 600 GCGCGATTAT TTGGCGTCAA ACATATTAAT TGTGGTTTGC TTGAAAAAAT CCCTGAGGAA 660 CAAATCATCG TCGCGCTTGG TGAATTATGT GACCGCGCAG AAGAATTAAT TATTGGTTTA 720 GAATTTATGC CATATAGCGG TGTAGCAGAC TTACAAGCAG CTTGGCGAGT AGCAGAAGCA 780 TGCGGCCGAG ATAATGCGCA ACTTATTTGT GACACGTGGC ACTGGGCTAG AGCAAACCAA 840 ACAGCAGAAT CTATCAAAAA CGTTCCCGCT GATCGGATTG TTTCCATCCA ACTATGCGAT 900 GTCCACGAAA CGCCTTACAA AGAACTTCGT GAGGAATCAC TTCATGATCG TCTAGCTCCT 960 GGAGAAGGCT ACGGAGATAC GGTCGGTTTT GCAAAAATTT TAAAAGAACA TGGTGTAAAT 1020 CCACGTGTGA TGGGAGTCGA AGTTATTTCA GACTCTATGG TAGCAACTGG TTTAGAGTAT 1080 GCCGCCCTTA AAGTATACAA TGCCACGAAA AAAGTATTAG ACGAAGCATG GCCAGAAATT 1140 TCTCCACGCT AAACACCTAC TCGCTTATGT GAAAATAATA ACGTAGTAGG AAGACTCCCT 1200 GTGAAAGGAA TGTGTTATTT TTGAAATTTA ATTCGATGTT TTCACCTATT GATATCGGGC 1260 CGATGAAGGT GCCT 1274 (2) INFORMATION FOR SEQ ID NO: 30: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1289 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (vi) ORIGINAL SOURCE: (B) STRAIN: L MONO 1324 D.F. (Xi) SEQUENCE DESCRIPTION: SEQ ID NO: 30: CAAATCTGTT AGGCACCTTC ATCGGCCCGA TATCAATAGG TGAAAACATC GAATTAAATT 60 TCAAAAATAA CACATTCCTT TCACAGGGAG TCTTCCTACT ACGTTATCAT TTTCACATAA 120 CTAAGTAGGT GTTTAGCGTG GAGAAATCTC TGGCCATGCT TCGTCTAATA CTTTTTTCGT 180 GGCATTGTAT ACTTTAAGAG CGGCATACTC TAAACCAGTT GCTACCATAG AGTCTGAAAT 240 AACTTCAACT CCCATCACAC GTGGATTTAC ACCATGCTCT TTTAAAATTT TTGCAAAACC 300 GACCGTATCT CCGTATCCTT CTCCAGGAGC TAAACGATCA TGAAGTGATT CTTCACGAAG 360 TTCTTTGTAA GGTGTTTCGT GGACATCGCA TAGTTGGATA GAAACAATCC GATCAGCGGG 420 AACATTTTTG ATAGATTCAG CTGTTTGATT TGCTCTAGCC CAGTGCCATG TGTCACAAAT 480 AAGTTGCGCG TTATCTCGTC CGCATGCTTC TGCTACTCGC CAAGCTGCTT GTAAGTCTGC 540 TACACCGCTA TATGGCATAA ATTCTAAACC AATAATTAAT TCTTCTGCGC GGTCACATAA 600 TTCACCAAGC GCGACAATGA TTTGTTCCTC AGGGATTTTT TCAAGCAAAC CACAATTAAT 660 ATGTTTGACG CCAAATAATC GCGCCATGTG GAAAGTTGTT TGCTCTTTCT TTTGTTGTTC 720 TGCTGTACGA TCTTCGGCAG TTCCCCACTG GGTTATGTAC TCCACTTCTG TTACTTTCAT 780 GTTATGCTCG TCTAAAATCC GCAACATGTC TTCATCGGTT AATCCGGCAG CTAGTGCATC 840 TACATAATTT TCTGCACGCA AGCCAATTCC GTCAAAACCA TTTTCCGCAG CGACTTTCAC 900 TCGTTTAGGA AAAGATACCT CCGTTCCTAG TGTGTAAGAG CTAATCGTGA TGGGGCATTT 960 TTTTAGATTG CCATTTGCAT TTGTCATAAA AATTATCTCC TCTCCATAAT AAAAATTACA 1020 AGAAACTTTG ATAATATTTT CACAAACACC AGTAAAAAAA TAAATTCCAC TAAATTAAAA 1080 ATCTCTGATG TGATAACGCC TTCAATAGTT AAAAATGGAA CTGGACAGTT AACCTATTCT 1140 ACCGTATATT GGTTTTTAAG GAATAGTTTA TTTCACTGGC GTAACTACAG TTTAATTGTA 1200 TTATGACTAT TCCATAAAAA CAAATTGGTA TTGTTCTATT AATTGATAGA TAAATTGCAT 1260 AGATAACTTT TTAGTTAGGA GAGAAGCAT 1289 (2) INFORMATION FOR SEQ ID NO: 31: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1289 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iv) ANTI-SENSE: YES (Vi) ORIGINAL SOURCE: (B) STRAIN: L MONO 1324 D.F. (xi) SEQUENCE DESCRIPTION: SEQ ID NO:31: ATGCTTCTCT CCTAACTAAA AAGTTATCTA TGCAATTTAT CTATCAATTA ATAGAACAAT 60 ACCAATTTGT TTTTATGGAA TAGTCATAAT ACAATTAAAC TGTAGTTACG CCAGTGAAAT 120 AAACTATTCC TTAAAAACCA ATATACGGTA GAATAGGTTA ACTGTCCAGT TCCATTTTTA 180 ACTATTGAAG GCGTTATCAC ATCAGAGATT TTTAATTTAG TGGAATTTAT TTTTTTACTG 240 GTGTTTGTGA AAATATTATC AAAGTTTCTT GTAATTTTTA TTATGGAGAG GAGATAATTT 300 TTATGACAAA TGCAAATGGC AATCTAAAAA AATGCCCCAT CACGATTAGC TCTTACACAC 360 TAGGAACGGA GGTATCTTTT CCTAAACGAG TGAAAGTCGC TGCGGAAAAT GGTTTTGACG 420 GAATTGGCTT GCGTGCAGAA AATTATGTAG ATGCACTAGC TGCCGGATTA ACCGATGAAG 480 ACATGTTGCG GATTTTAGAC GAGCATAACA TGAAAGTAAC AGAAGTGGAG TACATAACCC 540 AGTGGGGAAC TGCCGAAGAT CGTACAGCAG AACAACAAAA GAAAGAGCAA ACAACTTTCC 600 ACATGGCGCG ATTATTTGGC GTCAAACATA TTAATTGTGG TTTGCTTGAA AAAATCCCTG 660 AGGAACAAAT CATTGTCGCG CTTGGTGAAT TATGTGACCG CGCAGAAGAA TTAATTATTG 720 GTTTAGAATT TATGCCATAT AGCGGTGTAG CAGACTTACA AGCAGCTTGG CGAGTAGCAG 780 AAGCATGCGG ACGAGATAAC GCGCAACTTA TTTGTGACAC ATGGCACTGG GCTAGAGCAA 840 ATCAAACAGC TGAATCTATC AAAAATGTTC CCGCTGATCG GATTGTTTCT ATCCAACTAT 900 GCGATGTCCA CGAAACACCT TACAAAGAAC. TTCGTGAAGA ATCACTTCAT GATCGTTTAG 960 CTCCTGGAGA AGGATACGGA GATACGGTCG GTTTTGCAAA AATTTTAAAA GAGCATGGTG 1020 TAAATCCACG TGTGATGGGA GTTGAAGTTA TTTCAGACTC TATGGTAGCA ACTGGTTTAG 1080 AGTATGCCGC TCTTAAAGTA TACAATGCCA CGAAAAAAGT ATTAGACGAA GCATGGCCAG 1140 AGATTTCTCC ACGCTAAACA CCTACTTAGT TATGTGAAAA TGATAACGTA GTAGGAAGAC 1200 TCCCTGTGAA AGGAATGTGT TATTTTTGAA ATTTAATTCG ATGTTTTCAC CTATTGATAT 1260 CGGGCCGATG AAGGTGCCTA ACAGATTTG 1289 (2) INFORMATION FOR SEQ ID NO: 32: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 284 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: unknown (D) TOPOLOGY: unknown (ii) MOLECULE TYPE: protein (vi) ORIGINAL SOURCE: (B) STRAIN: L MONO ORF (xi) SEQUENCE- DESCRIPTION: SEQ ID NO: 32: Met Thr Asn Ala Asn Gly Asn Leu Lys Lys Cys Pro Ile Thr Ile Ser 1 5 10 15 Ser Tyr Thr Leu Gly Thr Glu Val Ser Phe Pro Lys Arg Val Lys Val 20 25 30 Ala Ala Glu Asn Gly Phe Asp Gly Ile Gly Leu Arg Ala Glu Asn Tyr 35 40 45 Val Asp Ala Leu Ala Ala Gly Leu Thr Asp Glu Asp Met Leu Arg Ile 50 55 60 Leu Asp Glu His Asn Met Lys Val Thr Glu Val Glu Tyr Ile Thr Gin 65 70 75 80 Trp Gly Thr Ala Glu Asp Arg Thr Ala Glu Gin Gin Lys Lys Glu Gin 85 90 95 Thr Thr Phe His Met Ala Arg Leu Phe Gly Val Lys His Ile Asn Cys 100 105 110 Gly Leu Leu Glu Lys Ile Pro Glu Glu Gin Ile Ile Val Ala Leu Gly 115 120 125 Glu Leu Cys Asp Arg Ala Glu Glu Leu Ile Ile Gly Leu Glu Phe Met 130 135 140 Pro Tyr Ser Gly Val Ala Asp Leu Gin Ala Ala Trp Arg Val Ala Glu 145 150 155 160 Ala Cys Gly Arg Asp Asn Ala Gin Leu Ile Cys Asp Thr Trp His Trp 165 170 17 * 5 Ala Arg Ala Asn Gin Thr Ala Glu Ser Ile Lys Asn Val Pro Ala Asp 180 185 190 Arg Ile Val Ser Ile Gin Leu Cys Asp Val His Glu Thr Pro Tyr Lys 195 200 205 Glu Leu Arg Glu Glu Ser Leu His Asp Arg Leu Ala Pro Gly Glu Gly 210 215 220 Tyr Gly Asp Thr Val Gly Phe Ala Lys Ile Leu Lys Glu His Gly Val 225 230 235 240 Asn Pro Arg Val Met Gly Val Glu Val Ile Ser Asp Ser Met Val Ala 245 250 255 Thr Gly Leu Glu Tyr Ala Ala Leu Lys Val Tyr Asn Ala Thr Lys Lys 260 265 270 Val Leu Asp Glu Ala Trp Pro Glu Ile Ser Pro Arg 275 280 (2) INFORMATION FOR SEQ ID NO: 33: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1329 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (vi) ORIGINAL SOURCE: (B) STRAIN: L INNOCUA 4450 D.F. (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 33: CATCTGTATT CGCATAGTTA TTACACATTG GAGATACAAC AAAACGATTT GGTACTCTCA 60 TAGGCCCGAT ATCAATCGGT GAGAACATCG AATTAAATTT CAAAAAAAAC ACTTCCCTTT 120 CAAGGTAGAA TCTTCTTGTT ACGTTACTTT TTTCACATGT TTAATTATTT TTTTATTTGG 180 GAGAAATTTC TGGCCATGCT TCGTCCAATA CTTTTTTCGT TGCATTATAT ACTTTGATGG 240 CAGCATATTC TAAACCAGTT TCTACCATGG AGTCGGATAT AACTTCAACG CCCATAACAC 300 GGGGGTTAAC GCCATGCTCT TTCAAGATTC GAGCAAAACC GACTGTATCG CCGTATCCCT 360 CGCCAGGAGC AAGTCGGTCA TGGAGAGATT CTTCCCGAAG TTCTTTGTAA GGTGTTTCGT 420 GTACGTCACA TAATTGGATG GAAACAATCC GGTCAGCGGG AACATTTTTG ATTGATTCTG 480 CTGTTTGGTT TGCTCTAGCC GAGTGCCAAG TGTCGCAAAT TAGTTGTGCA TTATCCCTGC 540 CACATGCTTC AGCTACACGC CAAGCTGCTG CTAAGTCTGC TACACCACTG TATGGCATAA 600 ACTCTAAACC GATAATTAAT TCTTCCGCAC GGTCACACAA TTCACCGAGT GCCGTAATGA 660 TTTGTTCTTC GGGGATTTTT TCAAGCAAAC CGCAGTTAAT ATGTTTGACG CCGAATAAAC 720 GCGCCATGTG GAAAGTAGTT TGTTCTTTCT TTTGCTGTTC GGCTGTGCGG TCCTCGGCGG 780 TTCCCCACTG AGTTATGTAT TCTACTTCTG TTACTTTGAT GTTATGCTCA TCTAAAATCC 840 GCAACATATC TTCATCAGTT AATCCAGCGG CTAGTGCGTC TACATAGTTT TCTGCACGTA 900 AGCCAATTCC ATCAAAACCA TTTTCTGCTG CGATTCTCAC TCGTTCAGGA AAAGATACCT 960 CCGTTCCAAG CGTGTAAGAG CTGATCGTGA TTGGGCATTT TTTTAGGTCG CCATTTGCAT 1020 TTGTCATAAA AATTATCTCC TCTCTAGAAT AAAAATTACA AGAAACTTTG ATAATATTTT 1080 CACAAACACC AGTAAAAAAA TAAATTCCCG TTCATTAAAT ATCGCTGATG TGATAACGCC 1140 TTCAATGTTT GAAATTTCAA CTGGACAGTT AACGTATTCT ACCGTATATT GGTTTTTAAG 1200 GAATAGTTTG TTCTGCTGGT GTAACTACAG TCTAATTGTA TTATGACTAT TCCATAAAAA 1260 CAAATTGGTA TTATTCTATT AATTGATAGA TAAATTGCAT AGATAATTTT TAGTAAGGAG 1320 AGAAGCCAT 1329 (2) INFORMATION FOR SEQ ID NO: 34: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1329 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iv) ANTI-SENSE: YES (vi) ORIGINAL SOURCE: (B) STRAIN: L INNOCUA 4450 D.F. (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 34: ATGGCTTCTC TCCTTACTAA AAATTATCTA TGCAATTTAT CTATCAATTA ATAGAATAAT 60 ACCAATTTGT TTTTATGGAA TAGTCATAAT ACAATTAGAC TGTAGTTACA CCAGCAGAAC 120 AAACTATTCC TTAAAAACCA ATATACGGTA GAATACGTTA ACTGTCCAGT TGAAATTTCA 180 AACATTGAAG GCGTTATCAC ATCAGCGATA TTTAATGAAC GGGAATTTAT TTTTTTACTG 240 GTGTTTGTGA AAATATTATC AAAGTTTCTT GTAATTTTTA TTCTAGAGAG GAGATAATTT 300 TTATGACAAA TGCAAATGGC GACCTAAAAA AATGCCCAAT CACGATCAGC TCTTACACGC 360 TTGGAACGGA GGTATCTTTT CCTGAACGAG TGAGAATCGC AGCAGAAAAT GGTTTTGATG 420 GAATTGGCTT ACGTGCAGAA AACTATGTAG ACGCACTAGC CGCTGGATTA ACTGATGAAG 480 ATATGTTGCG GATTTTAGAT GAGCATAACA TCAAAGTAAC AGAAGTAGAA TACATAACTC 540 AGTGGGGAAC CGCCGAGGAC CGCACAGCCG AACAGCAAAA GAAAGAACAA ACTACTTTCC 600 ACATGGCGCG TTTATTCGGC GTCAAACATA TTAACTGCGG TTTGCTTGAA AAAATCCCCG 660 AAGAACAAAT CATTACGGCA CTCGGTGAAT TGTGTGACCG TGCGGAAGAA TTAATTATCG 720 GTTTAGAGTT TATGCCATAC AGTGGTGTAG CAGACTTAGC AGCAGCTTGG CGTGTAGCTG 780 AAGCATGTGG CAGGGATAAT GCACAACTAA TTTGCGACAC TTGGCACTCG GCTAGAGCAA 840 ACCAAACAGC AGAATCAATC AAAAATGTTC CCGCTGACCG GATTGTTTCC ATCCAATTAT 900 GTGACGTACA CGAAACACCT TACAAAGAAC TTCGGGAAGA ATCTCTCCAT GACCGACTTG 960 CTCCTGGCGA GGGATACGGC GATACAGTCG GTTTTGCTCG AATCTTGAAA GAGCATGGCG 1020 TTAACCCCCG TGTTATGGGC GTTGAAGTTA TATCCGACTC CATGGTAGAA ACTGGTTTAG 1080 AATATGCTGC CATCAAAGTA TATAATGCAA CGAAAAAAGT ATTGGACGAA GCATGGCCAG 1140 AAATTTCTCC CAAATAAAAA AATAATTAAA CATGTGAAAA AAGTAACGTA ACAAGAAGAT 1200 TCTACCTTGA AAGGGAAGTG TTTTTTTTGA AATTTAATTC GATGTTCTCA CCGATTGATA 1260 TCGGGCCTAT GAGAGTACCA AATCGTTTTG TTGTATCTCC AATGTGTAAT AACTATGCGA 1320 ATACAGATG 1329 (2) INFORMATION FOR SEQ ID NO: 35: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1319 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: " DNA (genomic) (vi) ORIGINAL SOURCE: (B) STRAIN: L SEELIGERI 3327 D.F. (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 35: TATTTGCATA GTTATTACAC ATCGGCGAAA CCACGAAACG GTTTGGCACA CGCATAGGTC 60 CGATATCTAT TGGAGAAAAC ATCGAATTAA ATTTCAAAAA AAACACTTTC CTTTCAAAGG 120 GGGATTTTTA ACGTTATTAA TTTCACATAG CGATGCGTCA AGTTACTTTG GAGAAACTTC 180 TGGCCATGCT TCATCTAATA CTTTTTTAGT AGCATTATAA ACTTTAATTG CCGCATATTC 240 TAAACCTGTT TCTACCATCG AGTCTGAAAT CACTTCCACA CCCATAACAC GCGGATTTAC 300 ACCATGTTCT TTTAAAATAC GAGCAAAGCC TACAGTGTCG CCGTATCCTT CACCAGGTGC 360 TAATCGATCA TGGAGAGATT CTTCACGTAA TTCTTTGTAA GGAGTTTCGT GAACATCGCA 420 AAGTTGAATA GACACAATTC GGTCAGCAGG AATATTTTTG ATAGATTCTG CTGTTTGATT 480 TGCTCTAGCC CAGTGCCAAG TATCACAAAT CAGTTGCGCG TTATCTCGGC CACATGCTTC 540 TGCCACACGC CATGCTGCTG CTAAATCTGC TACACCGCTA TAAGGCATGA ATTCTAAACC 600 GATAATTAAT TCTTCAGCAC GGTCACAAAG TTCACCCAGA GCAGTAATGA TTTGTTCTTC 660 CGGAATCTTT TCAAGTAAAC CACAGTTAAT ATGTTTTACG CCGAATAAGC GCGCCATATG 720 AAAAGTGGTT TGTTCTTTCT TTTGTTGTTC TTTGGTGCGG TCGGAAGCGG TTCCCCATTG 780 CGTTATGTAT TCTACTTCTG TTACTTTGAT GTGATGTTCG TCCAAAATAC GCAACATATC 840 TTCATCGGTT AAGCCTGCTG CAAGTGCATC AACATAGTTT TCTGCACGTA AACCAATTCC 900 ATCAAAACCA TTTTCTGCTG CGATTCGTAC TCGTTCAGGA AAAGAAACCT CCGTTCCAAG 960 CGTGTAAGAA CTAATCGTGA TGGGGCATTT TTTTAAGTCG CCATTTACAT TTGTCATAAA 1020 AATTATCTCC TCTCTAGATT AAAATACAAG AAACTTTGAT AATAATTTCA CAATCACCAG 1080 CAAAAAAATA AATTCCTTTT TAGAATAAAA CGTCCTGAAG TGATAACGCA TTCAATCATT 1140 GAAAATCTGA CTGGACAGTT TTCGAATTCT ACCGTATATT GGTTTTTAAA GGATAGTTTG 1200 TCTCACTGGC TTAATTACAG TTTAATTGTA GTATGACTAT TCCATAAAAA CAAATTGGTA 1260 TTATTCTATT AATTGATAGA TAAATTGCAT AGATGCTTTT TAAAGAGGGG AGAAACCAT 1319 (2) INFORMATION FOR SEQ ID NO: 36: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1319 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iv) ANTI-SENSE: YES (vi) ORIGINAL SOURCE: (B) STRAIN: L SEELIGERI 3327 D.F. (xi) SEQUENCE DESCRIPTION: SEQ ID NO:36: ATGGTTTCTC CCCTCTTTAA AAAGCATCTA TGCAATTTAT CTATCAATTA ATAGAATAAT 60 ACCAATTTGT TTTTATGGAA TAGTCATACT ACAATTAAAC TGTAATTAAG CCAGTGAGAC 120 AAACTATCCT TTAAAAACCA ATATACGGTA GAATTCGAAA ACTGTCCAGT CAGATTTTCA ISO ATGATTGAAT GCGTTATCAC TTCAGGACGT TTTATTCTAA AAAGGAATTT ATTTTTTTGC 240 TGGTGATTGT GAAATTATTA TCAAAGTTTC TTGTATTTTA ATCTAGAGAG GAGATAATTT 300 TTATGACAAA TGTAAATGGC GACTTAAAAA AATGCCCCAT CACGATTAGT TCTTACACGC 360 TTGGAACGGA GGTTTCTTTT CCTGAACGAG TACGAATCGC AGCAGAAAAT GGTTTTGATG 420 GAATTGGTTT ACGTGCAGAA AACTATGTTG ATGCACTTGC AGCAGGCTTA ACCGATGAAG 480 ATATGTTGCG TATTTTGGAC GAACATCACA TCAAAGTAAC AGAAGTAGAA TACATAACGC 540 AATGGGGAAC CGCTTCCGAC CGCACCAAAG AACAACAAAA GAAAGAACAA ACCACTTTTC 600 ATATGGCGCG CTTATTCGGC GTAAAACATA TTAACTGTGG TTTACTTGAA AAGATTCCGG 660 AAGAACAAAT CATTACTGCT CTGGGTGAAC TTTGTGACCG TGCTGAAGAA TTAATTATCG 720 GTTTAGAATT CATGCCTTAT AGCGGTGTAG CAGATTTAGC AGCAGCATGG CGTGTGGCAG 780 AAGCATGTGG CCGAGATAAC GCGCAACTGA TTTGTGATAC TTGGCACTGG GCTAGAGCAA 840 ATCAAACAGC AGAATCTATC AAAAATATTC CTGCTGACCG AATTGTGTCT ATTCAACTTT 900 GCGATGTTCA CGAAACTCCT TACAAAGAAT TACGTGAAGA ATCTCTCCAT GATCGATTAG 960 CACCTGGTGA AGGATACGGC GACACTGTAG GCTTTGCTCG TATTTTAAAA GAACATGGTG 1020 TAAATCCGCG TGTTATGGGT GTGGAAGTGA TTTCAGACTC GATGGTAGAA ACAGGTTTAG 1080 AATATGCGGC AATTAAAGTT TATAATGCTA CTAAAAAAGT ATTAGATGAA GCATGGCCAG 1140 AAGTTTCTCC AAAGTAACTT GACGCATCGC TATGTGAAAT TAATAACGTT AAAAATCCCC 1200 CTTTGAAAGG AAAGTGTTTT TTTTGAAATT TAATTCGATG TTTTCTCCAA TAGATATCGG 1260 ACCTATGCGT GTGCCAAACC GTTTCGTGGT TTCGCCGATG TGTAATAACT ATGCAAATA 1319 (2) INFORMATION FOR SEQ ID NO: 37: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1304 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (vi) ORIGINAL SOURCE: (B) STRAIN: L WEISHIMERI 3359 D.F. (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 37: ATTACACATT GGAGATACAA CAAACCGATT AGGTACTTTC ATCGGGCCAA TATCGATAGG 60 TGAGAACATC GAATTAAATT TCAAAAAAAA CACTTCCCTT TCAAGATGGA ATCTAGATTA 120 CGTTATTATT TTCACATGTT TGAATACATT ATTTTGGAGA AATTTCTGGC CAAGCCTCGT 130 CTAATACTTT TTTCGTGGCA TTATATACTT TAATTGCAGC ATATTCTAGA CCAGTTTCAA 240 CCATAGAGTC AGATATTACT TCGACTCCCA TCACTCGTGG ATTTACACCA TGTTCTTTTA 300 GGATGCGTGC AAAACCAACT GTATCTCCAT ATCCTTCACC AGGTGGTAGT CGGTCATGAA 360 GCGATTCTTC ACGAAGTTCT TTGTATGGCG TTTCATGAAC ATCACACAAT TGGATAGAAA 420 CAATTCGATC AGCTGGGACA TTTTTGATAG ACTCTGCTGT TTGGTTTGCT CTTGCCCAGT 480 GCCAAGTATC GCAAATTAGT TGTGCGTTAT CTCTACCACA TGCTTCTGCA ACACGCCAAG 540 CTGCGGCTAA GTCTGCTACT CCGCTATACG GCATAAATTC TAAACCGATG ATTAATTCTT 600 CGGCACGATC ACATAACTCA CCAAGAGCAG TAATTATTTG CTCTTCTGGA ATTTTTTCAA 660 GTAAACCGCA GTTAATATGT TTTACACCGA ATAACCGAGC CATGTGGAAA GTGGTTTGCT 720 CTTTTTGTTG TTGAGCATCG GTTCGGTCTG CTTCAGTTCC CCACTGAGTT ATGTATTCTA 780 CTTCTGTTAC TTTGATATTA TGCTTGTCTA AAATCTGCAG CATGTCATCA TCAGTTAAGC 840 CAGCTGCAAG AGCGTCTACA TAATTTTCAG CTCGCAAGCC AATTCCGTCA AAACCATTTT 900 CTGCTGCAAT CTTTACACGT TCTGGGAAGG AAACCTCCGT TCCAAGTGTG TAAGAACTAA 960 TCGTGATGGG GCATTTTTTT AAGTTGCCAT TTGAATTTGT CATAAAAATT ATCTCCTCTC 1020 AAGAATGTAA ATTACAAGAA ACTTTGATAA TATTTTCACA AACACCAGTA AAAAAATAAA 1080 TTCCTTTTAA TTAAAAATCG CTGATGTGAT AACGCCTTCA ATGATCAAAA TACAACTGGA 1140 CAGTTAACGT ATTCTACCGT ATATTGGTTT TTAAGGAATA GTTTATTCTG CTGGTGTAAC 1200 TACAGTTTAA TTGTATTATG ACTATTCCAT AAAAACAAAT TGGTATTATT CTATTAATTG 1260 ATAGATAAAT TGCATAGATA CTTTTTAATA AGGGGAGAAG CCAT 1304 (2) INFORMATION FOR SEQ ID NO: 38: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1304 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iv) ANTI-SENSE: YES (vi) ORIGINAL' SOURCEJ (B) STRAIN: L WEISHIMERI 3359 D.F. (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 38: ATGGCTTCTC CCCTTATTAA AAAGTATCTA TGCAATTTAT CTATCAATTA ATAGAATAAT 60 ACCAATTTGT TTTTATGGAA TAGTCATAAT ACAATTAAAC TGTAGTTACA CCAGCAGAAT 120 AAACTATTCC TTAAAAACCA ATATACGGTA GAATACGTTA ACTGTCCAGT TGTATTTTGA 180 TCATTGAAGG CGTTATCACA TCAGCGATTT TTAATTAAAA GGAATTTATT TTTTTACTGG 240 TGTTTGTGAA AATATTATCA AAGTTTCTTG TAATTTACAT TCTTGAGAGG AGATAATTTT 300 TATGACAAAT TCAAATGGCA ACTTAAAAAA ATGCCCCATC ACGATTAGTT CTTACACACT 360 TGGAACGGAG GTTTCCTTCC CAGAACGTGT AAAGATTGCA GCAGAAAATG GTTTTGACGG 420 AATTGGCTTG CGAGCTGAAA ATTATGTAGA CGCTCTTGCA GCTGGCTTAA CTGATGATGA 480 CATGCTGCAG ATTTTAGACA AGCATAATAT CAAAGTAACA GAAGTAGAAT ACATAACTCA 540 GTGGGGAACT GAAGCAGACC GAACCGATGC TCAACAACAA AAAGAGCAAA CCACTTTCCA 600 CATGGCTCGG TTATTCGGTG TAAAACATAT TAACTGCGGT TTACTTGAAA AAATTCCAGA 660 AGAGCAAATA ATTACTGCTC TTGGTGAGTT ATGTGATCGT GCCGAAGAAT TAATCATCGG 720 TTTAGAATTT ATGCCGTATA GCGGAGTAGC AGACTTAGCC GCAGCTTGGC GTGTTGCAGA 780 AGCATGTGGT AGAGATAACG CACAACTAAT TTGCGATACT TGGCACTGGG CAAGAGCAAA 840 CCAAACAGCA GAGTCTATCA AAAATGTCCC AGCTGATCGA ATTGTTTCTA TCCAATTGTG 900 TGATGTTCAT GAAACGCCAT ACAAAGAACT TCGTGAAGAA TCGCTTCATG ACCGACTACC 960 ACCTGGTGAA GGATATGGAG ATACAGTTGG TTTTGCACGC ATCCTAAAAG AACATGGTGT 1020 AAATCCACGA GTGATGGGAG TCGAAGTAAT ATCTGACTCT ATGGTTGAAA CTGGTCTAGA 1080 ATATGCTGCA ATTAAAGTAT ATAATGCCAC GAAAAAAGTA TTAGACGAGG CTTGGCCAGA 1140 AATTTCTCCA AAATAATGTA TTCAAACATG TGAAAATAAT AACGTAATCT AGATTCCATC 1200 TTGAAAGGGA AGTGTTTTTT TTGAAATTTA ATTCGATGTT CTCACCTATC GATATTGGCC 1260 CGATGAAAGT ACCTAATCGG TTTGTTGTAT CTCCAATGTG TAAT 1304 (2) INFORMATION FOR SEQ ID NO: 39: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1328 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (vi) ORIGINAL SOURCE: (B) STRAIN: L IVANOVII 3340 D.F. (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 39: CCGTCTGTAT TTGCATAGTT ATTACACATT TGCGAAACAA CAAAACGGTT AGGTACTTTC 60 ATTGGTCCGA TATCTATTGG AGAAAACATC GAATTAAATT TCAAAAAAAA CACTTCCCTT 120 TCAAGATAGA ATTTTTCTTT CGTTATTAAT TTCACATAGT ATTGTATCAG ATTATTTTGG 180 TGACACTTCG GGCCATGCTT CGTCTAATAC TTTTTTTGTG GCATTGTATA CTTTAATTGC 240 GGTATATTCT AAGCCAGTTT CTACCATGGA ATCAGATATT ACTTCTACTC CCATGACACG 300 TGGACTTACA CCATGCTCTT TTAAAATACG AGCAAAACCA ATCGTGTCCC CGTATCCTTC 360 ACCAGGAGCT AGTCTATCAT GCAGTGACTC TTCGCGAAGC TCTTTATAGG GCGTTTCATG 420 GACGTCACAG AGTTGAATTG AAACAATCCG ATCAGCAGGT ACATTTTTGA TAGATTCTGC 480 TGTTTGGTTT GCTCTTGCCC AGTGCCATGT GTCACAAATT AGTTGGGCGT TATCTCTGCC 540 GCAAGCCTCT GCCACACGCC ATGCTGCTGC CAAATCTGCT ACTCCGCTGT AAGGCATGAA 600 TTCTAAACCA ATAATCAATT CTTCTGCACG GTCGCAAAGT TCACCAAGAG CAGTAATGAT 660 TTGGTCTTCG GGGATTTTTT CCAATAAACC ACAATTAATA TGTTTTACAC CGAATAAGCG 720 AGCCATGTGG AAGGTAGTTT GTTCTTTCTT TTGTTGCTCG AAAGTGCGGT CAGAAGCGGT 780 TCCCCACTGC GTTATGTATT CTACTTCAGT AACTTTGATG TGATGCTCAT CTAAAATCCT 840 TAACATATCT TCATCAGTCA AGCCAGCTGC CAGTGCATCG ACATAATTTT CGGCGCGTAA 900 ACCAATTCCG TCAAAACCAT TTTCTGCTGC AATTCGTACT CGTTCAGGAA AAGAAACCTC 960 CGTTCCTAAG GTATAAGAGC TAATCGTGAT GGGGCATTTT TTTAGGTTGC CATTTGCATT 1020 TGTCATAAAA ATTATCTCCT CTCTAGATTA AAACACAAGA AACTTTGATA ATGTTTTCAC 1080 AATCACCAGC AAAAAAATAA AATCCATTCA CTTAGAAAAC TTTCTAATGT GAGAACGCAT 1140 TCAATAGTTA GAAAATTGAC TGGACAGTTT TCACATTCTA CCGTATATTG GTTTTTAAAG 1200 GTTAGTTTAT TTCACTGGCA TAACTACTGT TTAATTGTAG TATGACTATT CCATAAAAAC 1260 AAATTGGTAT TATTCTATTA ATCGATAGAT AAATTGCATA GATTATTTTT AACAAGGAGA 1320 GAACCCAT 1328 (2) INFORMATION FOR SEQ ID NO: 40: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1328 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY.: linear (ii) MOLECULE TYPE: DNA (genomic) (iv) ANTI-SENSE: YES (vi) ORIGINAL SOURCE: (B) STRAIN: L IVANOVII 3340 D.F. (xi) SEQUENCE DESCRIPTION: SEQ ID NO:40: ATGGGTTCTC TCCTTGTTAA AAATAATCTA TGCAATTTAT CTATCGATTA ATAGAATAAT 60 ACCAATTTGT TTTTATGGAA TAGTCATACT ACAATTAAAC AGTAGTTATG CCAGTGAAAT 120 AAACTAACCT TTAAAAACCA ATATACGGTA GAATGTGAAA ACTGTCCAGT CAATTTTCTA 180 ACTATTGAAT GCGTTCTCAC ATTAGAAAGT TTTCTAAGTG AATGGATTTT ATTTTTTTGC 240 TGGTGATTGT GAAAACATTA TCAAAGTTTC TTGTGTTTTA ATCTAGAGAG GAGATAATTT 300 TTATGACAAA TGCAAATGGC AACCTAAAAA AATGCCCCAT CACGATTAGC TCTTATACCT 360 TAGGAACGGA GGTTTCTTTT CCTGAACGAG TACGAATTGC AGCAGAAAAT GGTTTTGACG 420 GAATTGGTTT ACGCGCCGAA AATTATGTCG ATGCACTGGC AGCTGGCTTG ACTGATGAAG 480 ATATGTTAAG GATTTTAGAT GAGCATCACA TCAAAGTTAC TGAAGTAGAA TACATAACGC 540 AGTGGGGAAC CGCTTCTGAC CGCACTTTCG AGCAACAAAA GAAAGAACAA ACTACCTTCC 600 ACATGGCTCG CTTATTCGGT GTAAAACATA TTAATTGTGG TTTATTGGAA AAAATCCCCG 660 AAGACCAAAT CATTACTGCT CTTGGTGAAC TTTGCGACCG TGCAGAAGAA TTGATTATTG 720 GTTTAGAATT CATGCCTTAC AGCGGAGTAG CAGATTTGGC AGCAGCATGG CGTGTGGCAG 780 AGGCTTGCGG CAGAGATAAC GCCCAACTAA TTTGTGACAC ATGGCACTGG GCAAGAGCAA 840 ACCAAACAGC AGAATCTATC AAAAATGTAC CTGCTGATCG GATTGTTTCA ATTCAACTCT 900 GTGACGTCCA TGAAACGCCC TATAAAGAGC TTCGCGAAGA GTCACTGCAT GATAGACTAG 960 CTCCTGGTGA AGGATACGGG GACACGATTG GTTTTGCTCG TATTTTAAAA GAGCATGGTG 1020 TAAGTCCACG TGTCATGGGA GTAGAAGTAA TATCTGATTC CATGGTAGAA ACTGGCTTAG 1080 AATATACCGC AATTAAAGTA TACAATGCCA CAAAAAAAGT ATTAGACGAA GCATGGCCCG 1140 AAGTGTCACC AAAATAATCT GATACAATAC TATGTGAAAT TAATAACGAA AGAAAAATTC 1200 TATCTTGAAA GGGAAGTGTT TTTTTTGAAA TTTAATTCGA TGTTTTCTCC AATAGATATC 1260 GGACCAATGA AAGTACCTAA CCGTTTTGTT GTTTCGCAAA TGTGTAATAA CTATGCAAAT 1320 ACAGACGG • 1328 (2) INFORMATION FOR SEQ ID NO: 41: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 284 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: unknown (D) TOPOLOGY: unknown (ii) MOLECULE TYPE: protein (vi) ORIGINAL SOURCE: (B) STRAIN: L MONO 647 ORF (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 41: Met Thr Asn Ala Asn Gly Asn Leu Lys Lys Cys Pro Ile Thr Ile Ser 1 5 10 15 Ser Tyr Thr Leu Gly Thr Glu Val Ser Phe Pro Lys Arg Val Lys Val 20 25 30 Ala Ala Glu Asn Gly Phe Asp Gly Ile Gly Leu Arg Ala Glu Asn Tyr 35 40 45 Val Asp Ala Leu Ala Ala Gly Leu Thr Asp Glu Asp Met Leu Arg lie 50 55 60 Leu Asp Glu His Asn Met Lys Val Thr Glu Val Glu Tyr Ile Thr Gin 65 70 75 80 Trp Gly Thr Ala Glu Asp Arg Thr Ala Glu Gin Gin Lys Lys Glu Gin 85 90 95 Thr Thr Phe His Met Ala Arg Leu Phe Gly Val Lys His Ile Asn Cys 100 105 110 Gly Leu Leu Glu Lys Ile Pro Glu Glu Gin Ile Ile Val Ala Leu Gly 115 120 125 Glu Leu Cys Asp Arg Ala Glu Glu Leu Ile Ile Gly Leu Glu Phe Met 130 135 140 Pro Tyr Ser Gly Val Ala Asp Leu Gin Ala Ala Trp Arg Val Ala Glu 145 150 155 160 Ala Cys Gly Arg Asp Asn Ala Gin Leu Ile Cys Asp Thr Trp His Trp 165 170 175 Ala Arg Ala Asn Gin Thr Ala Glu Ser Ile Lys Asn Val Pro Ala Asp 180 185 190 Arg Ile Val Ser Ile Gin Leu Cys Asp Val His Glu Thr Pro Tyr Lys 195 200 205 Glu Leu Arg Glu Glu Ser Leu His Asp Arg Leu Ala Pro Gly Glu Gly 210 215 220 Tyr Gly Asp Thr Val Gly Phe Ala Lys Ile Leu Lys Glu His Gly Val 225 230 235 240 Asn Pro Arg Val Met Gly Val Glu Val Ile Ser Asp Ser Met Val Ala 245 250 255 Thr Gly Leu Glu Tyr Ala Ala Leu Lys Val Tyr Asn Ala Thr Lys Lys 260 265 270 Val Leu Asp Glu Ala Trp Pro Glu Ile Ser Pro Arg 275 280 (2) INFORMATION FOR SEQ ID NO: 42: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 284 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: unknown (D) TOPOLOGY: unknown (ii) MOLECULE TYPE: protein (vi) ORIGINAL SOURCE: (B) STRAIN: L MONO 4450 ORF (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 42: Met Thr Asn Ala Asn Gly Asp Leu Lys Lys Cys Pro Ile Thr Ile Ser 1 5 10 15 Ser Tyr Thr Leu Gly Thr Glu Val Ser Phe Pro Glu Arg Val Arg Ile 20 25 30 Ala Ala Glu Asn Gly Phe Asp Gly Ile Gly Leu Arg Ala Glu Asn Tyr 35 40 45 Val Asp Ala Leu Ala Ala Gly Leu Thr Asp Glu Asp Met Leu Arg Ile 5θ " 55 60 Leu Asp Glu His Asn Ile Lys Val Thr Glu Val Glu Tyr Ile Thr Gin 65 70 75 80 Trp Gly Thr Ala Glu Asp Arg Thr Ala Glu Gin Gin Lys Lys Glu Gin 85 90 95 Thr Thr Phe His Met Ala Arg Leu Phe Gly Val Lys His Ile Asn Cys 100 105 110 Gly Leu Leu Glu Lys Ile Pro Glu Glu Gin Ile Ile Thr Ala Leu Gly 115 120 125 Glu Leu Cys Asp Arg Ala Glu Glu Leu Ile Ile Gly Leu Glu Phe Met 130 135 140 Pro Tyr Ser Gly Val Ala Asp Leu Ala Ala Ala Trp Arg Val Ala Glu 145 150 155 160 Ala Cys Gly Arg Asp Asn Ala Gin Leu Ile Cys Asp Thr Trp His Ser 165 170 175 Ala Arg Ala Asn Gin Thr Ala Glu Ser Ile Lys Asn Val Pro Ala Asp 180 185 190 Arg Ile Val Ser Ile Gin Leu Cys Asp Val His Glu Thr Pro Tyr Lys 195 200 205 Glu Leu Arg Glu Glu Ser Leu His Asp Arg Leu Ala Pro Gly Glu Gly 210 215 220 Tyr Gly Asp Thr Val Gly Phe Ala Arg Ile Leu Lys Glu His Gly Val 225 • 230 235 240 Asn Pro Arg Val Met Gly Val Glu Val Ile Ser Asp Ser Met Val Glu 245 250 255 Thr Gly Leu Glu Tyr Ala Ala Ile Lys Val Tyr Asn Ala Thr Lys Lys 260 265 270 Val Leu Asp Gin Ala Trp Pro Glu Ile Ser Pro Lys 275 280 (2) INFORMATION FOR SEQ ID NO: 3: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 284 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: unknown (D) TOPOLOGY: unknown (ii) MOLECULE TYPE: protein (vi) ORIGINAL SOURCE: (B) STRAIN: L MONO 3340 ORF (Xi) SEQUENCE DESCRIPTION: SEQ ID NO: 43: Met Thr Asn Ala Asn Gly Asn Leu Lys Lys Cys Pro Ile Thr Ile Ser 1 5 10 15 Ser Tyr Thr Leu Gly Thr Glu Val Ser Phe Pro Glu Arg Val Arg Ile 20 25 30 Ala Ala Glu Asn Gly Phe Asp Gly Ile Gly Leu Arg Ala Glu Asn Tyr 35 40 45 Val Asp Ala Leu Ala Ala Gly Leu Thr Asp Glu Asp Met Leu Arg Ile 50 55 60 Leu Asp Glu His His Ile Lys Val Thr Glu Val Glu Tyr Ile Thr Gin 65 70 75 80 Trp Gly Thr Ala Ser Asp Arg Thr Phe Glu Gin Gin Lys Lys Glu Gin 85 90 95 Thr Thr Phe His Met Ala Arg Leu Phe Gly Val Lys His Ile Asn Cys 100 105 110 Gly Leu Leu Glu Lys Ile Pro Glu Asp Gin Ile Ile Thr Ala Leu Gly 115 120 125 Glu Leu Cys Asp Arg Ala Glu Glu Leu Ile Ile Gly Leu Glu Phe Met 130 135 140 Pro Tyr Ser Gly Val Ala Asp Leu Ala Ala Ala Trp Arg Val Ala Glu 145 150 155 160 Ala Cys Gly Arg Asp Asn Ala Gin Leu Ile Cys Asp Thr Trp His Trp 165 170 175 Ala Arg Ala Asn Gin Thr Ala Glu Ser Ile Lys Asn Val Pro Ala Asp 180 185 190 Arg Ile Val Ser Ile Gin Leu Cys Asp Val His Glu Thr Pro Tyr Lys 195 200 205 Glu Leu Arg Glu Glu Ser Leu His Asp Arg Leu Ala Pro Gly Glu Gly 210 215 220 Tyr Gly Asp Thr Ile Gly Phe Ala Arg Ile Leu Lys Glu His Gly Val 225 230 235 240 Ser Pro Arg Val Met Gly Val Glu Val Ile Ser Asp Ser Met Val Glu 245 250 255 Thr Gly Leu Glu Tyr Thr Ala Ile Lys Val Tyr Asn Ala Thr Lys Lys 260 265 270 Val Leu Asp Glu Ala Trp Pro Glu Val Ser Pro Lys 275 280 (2) INFORMATION FOR SEQ ID NO: 44: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 284 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: unknown (D) TOPOLOGY: unknown (ii) MOLECULE TYPE: protein (vi) ORIGINAL SOURCE: (B) STRAIN: L MONO 3327 ORF (x ) SEQUENCE DESCRIPTION: SEQ ID NO: 44: Met Thr Asn Val Asn Gly Asp Leu Lys Lys Cys Pro Ile Thr Ile Ser 1 5 10 15 Ser Tyr Thr Leu Gly Thr Glu Val Ser Phe Pro Glu Arg Val Arg lie 20 25 30 Ala Ala Glu Asn Gly Phe Asp Gly Ile Gly Leu Arg Ala Glu Asn Tyr 35 40 45 Val Asp Ala Leu Ala Ala Gly Leu Thr Asp Glu Asp Met Leu Arg Ile 50 55 60 Leu Asp Glu His His Ile Lys Val Thr Glu Val Glu Tyr Ile Thr Gin 65 70 75 80 Trp Gly Thr Ala Ser Asp Arg Thr Lys Glu Gin Gin Lys Lys Glu Gin 85 90 95 Thr Thr Phe His Met Ala Arg Leu Phe Gly Val Lys His Ile Asn Cys 100 105 110 Gly Leu Leu ' Glu Lys Ile Pro Glu Glu Gin Ile Ile Thr Ala Leu Gly 115 120 125 Glu Leu Cys Asp Arg Ala Glu Glu Leu Ile Ile Gly Leu Glu Phe Met 130 135 140 Pro Tyr Ser Gly Val Ala Asp Leu Ala Ala Ala Trp Arg Val Ala Glu 145 150 155 160 Ala Cys Gly Arg Asp Asn Ala Gin Leu Ile Cys Asp Thr Trp His Trp 165 170 175 Ala Arg Ala Asn Gin Thr Ala Glu Ser Ile Lys Asn Ile Pro Ala Asp 180 185 190 Arg Ile Val Ser Ile Gin Leu Cys Asp Val His Glu Thr Pro Tyr Lys 195 200 205 Glu Leu Arg Glu Glu Ser Leu His Asp Arg Leu Ala Pro Gly Glu Gly 210 215 220 Tyr Gly Asp Thr Val Gly Phe Ala Arg Ile Leu Lys Glu His Gly Val 225 230 235 240 Asn Pro Arg Val Met Gly Val Glu Val Ile Ser Asp Ser Met Val Glu 245 250 255 Thr Gly Leu Glu Tyr Ala Ala Ile Lys Val Tyr Asn Ala Thr Lys Lys 260 265 270 Val Leu Asp Glu Ala Trp Pro Glu Val Ser Pro Lys 275 280 (2) INFORMATION FOR SEQ ID NO:45: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 284 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: unknown (D) TOPOLOGY: unknown (ii) MOLECULE TYPE: protein (vi) ORIGINAL SOURCE: (B) STRAIN: L MONO 3359 ORF (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 45: Met Thr Asn Ser Asn Gly Asn Leu Lys Lys Cys Pro Ile Thr Ile Ser 1 5 10 15 Ser Tyr Thr Leu Gly Thr Glu Val Ser Phe Pro Glu Arg Val Lys Ile 20 ' 25 30 Ala Ala Glu Asn Gly Phe Asp Gly Ile Gly Leu Arg Ala Glu Asn Tyr 35 40 45 Val Asp Ala Leu Ala Ala Gly Leu Thr Asp Asp Asp Met Leu Gin Ile 50 55 60 Leu Asp Lys His Asn Ile Lys Val Thr Glu Val Glu Tyr Ile Thr Gin 65 70 75 80 Trp Gly Thr Glu Ala- Asp Arg Thr Asp Ala Gin Gin Gin Lys Glu Gin 85 90 95 Thr Thr Phe His Met Ala Arg Leu Phe Gly Val Lys His Ile Asn Cys 100 105 110 Gly Leu Leu Glu Lys Ile Pro Glu Glu Gin Ile Ile Thr Ala Leu Gly 115 120 125 Glu Leu Cys Asp Arg Ala Glu Glu Leu Ile Ile Gly Leu Glu Phe Met 130 135 140 Pro Tyr Ser Gly Val Ala Asp Leu Ala Ala Ala Trp Arg Val Ala Glu 145 150 155 160 Ala Cys Gly Arg Asp Asn Ala Gin Leu Ile Cys Asp Thr Trp His Trp 165 170 175 Ala Arg Ala Asn Gin Thr Ala Glu Ser Ile Lys Asn Val Pro Ala Asp 180 185 190 Arg Ile Val Ser Ile Gin Leu Cys Asp Val His Glu Thr Pro Tyr Lys 195 200 205 Glu Leu Arg Glu Glu Ser Leu His Asp Arg Leu Pro Pro Gly Glu Gly 210 215 220 Tyr Gly Asp Thr Val Gly Phe Ala Arg Ile Leu Lys Glu His Gly Val 225 230 235 240 Asn Pro Arg Val Met Gly Val Glu Val Ile Ser Asp Ser Met Val Glu 245 250 255 Thr Gly Leu Glu Tyr Ala Ala Ile Lys Val Tyr Asn Ala Thr Lys Lys 260 265 270 Val Leu Asp Glu Ala Trp Pro Glu Ile Ser Pro Lys 275 280 (2) INFORMATION FOR SEQ ID NO: 46: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 26 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 46: GCGATACGAC AAATCTGTTA GGCACC 26 (2) INFORMATION FOR SEQ ID NO: 47: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 26 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 47: GAGATACAAC AAAACGATTT GGTACT 26 (2) INFORMATION FOR SEQ ID NO: 48: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 26 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:48: GCGAAACCAC GAAACGGTTT GGCACA 26 (2) INFORMATION FOR SEQ ID NO: 9: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 26 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 9: GAGATACAAC AAACCGATTA GGTACT 26 (2) INFORMATION FOR SEQ ID NO: 50: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 26 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:50: GCGAAACAAC AAAACGGTTA GGTACT 26 (2) INFORMATION FOR SEQ ID NO: 51: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 27 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 51: CATTCCTTTC ACAGGGAGTC TTCCTAC 27 (2) INFORMATION FOR SEQ ID NO: 52: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 28 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 52: CTTCCCTTTC AAGGTAGAAT CTTCTTGT 28 (2) INFORMATION FOR SEQ ID NO: 53: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 25 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:53: CTTTCCTTTC AAAGGGGGAT TTTTA 25 (2) INFORMATION FOR SEQ ID NO: 54: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 26 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 54: CTTCCCTTTC AAGATGGAAT CTAGAT 26 ( 2 ) INFORMATION FOR SEQ ID NO : 55 : ( i ) SEQUENCE CHARACTERI STICS : (A) LENGTH : 28 bas e pai rs ( B ) TYPE : nuclei c acid ( C ) STRANDEDNESS : single ( D ) TOPOLOGY : linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:55: CTTCCCTTTC AAGATAGAAT TTTTTCTT 28 (2) INFORMATION FOR SEQ ID NO:56: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 26 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 56: TAGTTGGATG GAAACAATCC GATCAG 26 (2) INFORMATION FOR SEQ ID NO: 57: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 26 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 57: TAGTTGGATA GAAACAATCC GATCAG 26 (2) INFORMATION FOR SEQ ID NO: 58: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH; 26 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 58: TAATTGGATG GAAACAATCC GGTCAG 26 (2) INFORMATION FOR SEQ ID NO: 59: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 26 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (11) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:59: AAGTTGAATA GACACAATTC GGTCAG 26 (2) INFORMATION FOR SEQ ID NO: 60: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 26 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 60: CAATTGGATA GAAACAATTC GATCAG 26 (2) INFORMATION FOR SEQ ID NO: 61: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 26 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 61: GAGTTGAATT GAAACAATCC GATCAG 26 (2) INFORMATION FOR SEQ ID NO: 62: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 27 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 62: TTTGTTGTTC TGCTGTACGA TCTTCGG 27 (2) INFORMATION FOR SEQ ID NO: 63: (i) . SEQUENCE CHARACTERISTICS: (A) LENGTH: 27 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 63: TTTGCTGTTC GGCTGTGCGG TCCTCGG 27 (2) INFORMATION FOR SEQ ID NO: 64: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 27 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 64: TTTGTTGTTC TTTGGTGCGG TCGGAAG 27 (2) INFORMATION FOR SEQ ID. NO:65: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 27 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 65: GTTGTTGAGC ATCGGTTCGG TCTGCTT 27 (2) INFORMATION FOR SEQ ID NO: 66: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 27 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 66: TTTGTTGCTC GAAAGTGCGG TCAGAAG 27 (2) INFORMATION FOR SEQ ID NO: 67: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 26 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (Xi) SEQUENCE DESCRIPTION: SEQ ID NO: 67: AAATCCCTGA GGAACAAATC ATCGTC 26 (2) INFORMATION FOR SEQ ID NO: 68: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 26 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 68: AAATCCCTGA GGAACAAATC ATTGTC 26 (2) INFORMATION FOR SEQ ID NO: 69: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 26 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 69: AAATCCCCGA AGAACAAATC ATTACG 26 (2) INFORMATION FOR SEQ ID NO: 70: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 26 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 70: AGATTCCGGA AGAACAAATC ATTACT 26 (2) INFORMATION FOR SEQ ID NO: 71: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 26 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 71: AAATTCCAGA AGAGCAAATA ATTACT 26 (2) INFORMATION FOR SEQ ID NO: 72: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 26 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:72: AAATCCCCGA AGACCAAATC ATTACT 26 (2) INFORMATION FOR SEQ ID NO: 73: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 27 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 73: GGTAGAATAG GTTAACTGTC CAGTTCC 27 (2) INFORMATION FOR SEQ ID NO: 74: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 27 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 74: GGTAGAATAC GTTAACTGTC CAGTTGA 27 (2) INFORMATION FOR SEQ ID NO: 75: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 27 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 75: GGTAGAATTC GAAAACTGTC CAGTCAG 27 (2) INFORMATION FOR SEQ ID NO: 76: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 27 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 76: GGTAGAATAC GTTAACTGTC CAGTTGT 27 (2) INFORMATION FOR SEQ ID NO: 77: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 27 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 77: GGTAGAATGT GAAAACTGTC CAGTCAA 27 (2) INFORMATION FOR SEQ ID NO: 78: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 28 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 78: TACAATTAGA CTGTAGTTAC GCCAGTGA 28 (2) INFORMATION FOR SEQ ID NO: 79: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 28 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 79: TACAATTAAA CTGTAGTTAC GCCAGTGA 28 (2) INFORMATION FOR SEQ ID NO: 80: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 28 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 80: TACAATTAGA CTGTAGTTAC ACCAGCAG 28 (2) INFORMATION FOR SEQ ID NO: 81: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 28 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 81: TACAATTAAA CTGTAATTAA GCCAGTGA 28 (2) INFORMATION FOR SEQ ID NO: 82: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 28 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 82: TACAATTAAA CTGTAGTTAC ACCAGCAG 28 (2) INFORMATION FOR SEQ ID NO: 83: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 28 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 83: TACAATTAAA CAGTAGTTAT GCCAGTGA 28 (2) INFORMATION FOR SEQ ID NO: 84: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 30 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 84: TTTGATAGAT TCTGCTGTTT GGTTTGCTCT 30 (2) INFORMATION FOR SEQ ID NO: 85: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 30 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:85: TTTGATAGAT TCAGCTGTTT GATTTGCTCT 30 (2) INFORMATION FOR SEQ ID NO: 86: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 30 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 86: TTTGATTGAT TCTGCTGTTT GGTTTGCTCT 30 (2) INFORMATION FOR SEQ ID NO: 87: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 30 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 87: TTTGATAGAT TCTGCTGTTT GATTTGCTCT 30 (2) INFORMATION FOR SEQ ID NO: 88: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 30 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 88: TTTGATAGAC TCTGCTGTTT GGTTTGCTCT 30 (2) INFORMATION FOR SEQ ID NO: 89: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 30 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 89: TGCTGTTTGG TTTGCTCTAG CCCAGTGCCA 30 (2) INFORMATION FOR SEQ ID NO: 90: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 30 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 90: AGCTGTTTGA TTTGCTCTAG CCCAGTGCCA 30 (2) INFORMATION FOR SEQ ID NO: 91: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 30 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 91: TGCTGTTTGG TTTGCTCTAG CCGAGTGCCA 30 (2) INFORMATION FOR SEQ ID NO: 92: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 30 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 92: TGCTGTTTGA TTTGCTCTAG CCCAGTGCCA 30 (2) INFORMATION FOR SEQ ID NO: 93: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 30 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 93: TGCTGTTTGG TTTGCTCTTG CCCAGTGCCA 30 (2) INFORMATION FOR SEQ ID NO: 94: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 30 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 94: TTGCATTTGT CATAAAAATT ATCTCCTCTC 30 (2) INFORMATION FOR SEQ ID NO: 95: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 30 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 95: TTACATTTGT CATAAAAATT ATCTCCTCTC 30 (2) INFORMATION FOR SEQ ID NO: 96: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 30 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 96: TTGAATTTGT CATAAAAATT ATCTCCTCTC 30 (2) INFORMATION FOR SEQ ID NO: 97: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 30 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 97: CGCTGCGGAA AACGGTTTTG ACGGATTTGG 30 (2) INFORMATION FOR SEQ ID NO: 98: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 30 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 98: CGCTGCGGAA AAAGGTTTTG ACGGATTTGG 30 (2) INFORMATION FOR SEQ ID NO: 99: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 30 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 99: CGCAGCAGAA AACGGTTTTG ATGGATTTGG 30 ( 2 ) INFORMATION FOR SEQ I D NO : 100 : ( i ) SEQUENCE CHARACTERI STICS : (A) LENGTH : 30 bas e pai rs ( B ) TYPE : nucleic acid ( C ) STRANDEDNESS : single ( D ) TOPOLOGY : linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 100: TGCAGCAGAA AACGGTTTTG ACGGATTTGG 30 (2) INFORMATION FOR SEQ ID NO: 101: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 30 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 101: AAAAAAATGC CCCATCACGA TTAGCTCTTA 30 (2) INFORMATION FOR SEQ ID NO: 102: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 30 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 102: AAAAAAATGC CCAATCACGA TCAGCTCTTA 30 (2) INFORMATION FOR SEQ ID NO: 103: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 30 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 103: AAAAAAATGC CCCATCACGA TTAGTTCTTA 30 (2) INFORMATION FOR SEQ ID NO: 104: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 30 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 104: AAATGCAAAT GGCAACCTAA AAAAATGCCC 30 (2) INFORMATION FOR SEQ ID NO: 105: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 30 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 105: AAATGCAAAT GGCAATCTAA AAAAATGCCC 30 (2) INFORMATION FOR SEQ ID NO: 106: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 30 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 106: AAATGCAAAT GGCGACCTAA AAAAATGCCC 30 (2) INFORMATION FOR SEQ ID NO: 107: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 30 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 107: AAATGTAAAT GGCGACTTAA AAAAATGCCC 30 (2) INFORMATION FOR SEQ ID NO: 108: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 30 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 108: AAATTCAAAT GGCAACTTAA AAAAATGCCC 30 (2) INFORMATION FOR SEQ ID NO: 109: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 30 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 109: CAATACCAAT TTGTTTTTAT GGAATAGTCA 30 (2) INFORMATION FOR SEQ ID NO: 110: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 30 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 110: TAATACCAAT TTGTTTTTAT GGAATAGTCA 30

Claims: D-1065-A CLAIMS What is claimed is: 1. A method for determining whether an unknown bacterium is a Listeria monocytogenes, comprising 5 (A) amplifying genomic DNA from (i) a positive test panel of Listeria monocytogenes strains and (ii) a negative test panel of non- monocytogenes Listeria strains with a primer derived from a pre-marker diagnostic fragment for Listeria monocytogenes selected from the group of nucleic acids 10 corresponding to SEQ LD NOS: 17, 18, and 19 to yield a 1300 bp diagnostic fragment for each of the positive and negative test panels; (B) selecting at least one Listeria monocytogenes diagnostic marker contained within the diagnostic fragment by 15 comparing the diagnostic fragment obtained from the amplification of the positive test panel with the diagnostic fragment obtained from the amplification of the negative test panel whereby at least one highly conserved region in the diagnostic fragment of the positive test panel is identified 20 which is less than 90% homologous to any member of the negative test panel; (C) designing at least one amplification primer corresponding to the at least one diagnostic marker identified in step (B); and 25 (D) amplifying genomic DNA of the unknown bacterium under suitable annealing temperatures with the at least one amplification primer of step (C), whereby obtaining at least one amplification product indicates that the unknown bacterium is a Listeria monocytogenes. 30 2. The method of Claim 1 wherein the Listeria monocytogenes pre- marker diagnostic fragment is selected from the group consisting of nucleic acids corresponding to SEQ LD NOS:20-23. 3. The method of Claim 1 wherein the diagnostic fragment is at least 83% homologous to SEQ ID NOS:24-31 and 33-40. 35 4. The method of Claim 1 wherein the diagnostic fragment is selected from the group of consisting nucleic acids corresponding to SEQ LD NOS: 24-31 and 33-40. 5. The method of Claim 1 wherein at least one diagnostic marker selected in step (B) is selected from the group consisting of nucleic acids corresponding to SEQ ID NOS:46-83. 6. The method of Claim 1 wherein the at least one amplification primer is about 15 to 30 bp in length. 7. The method of Claim 1 wherein the suitable annealing temperature is in the range of about 60 °C to 70 °C. 8. A method for determining whether an unknown bacterium is a member of the genus Listeria, comprising (A) amplifying genomic DNA from (i) a positive test panel of Listeria monocytogenes strains and (ii) a negative test panel of non-monocytogenes Listeria strains with a primer derived from a pre-marker diagnostic fragment for Listeria monocytogenes strains selected from the group consisting of nucleic acids corresponding to SEQ LD NOS: 17, 18, and 19 to yield a 1300 bp diagnostic fragment for each of the positive and negative test panels; (B) selecting at least one Listeria genus-specific diagnostic marker contained within the diagnostic fragment by comparing the diagnostic fragment obtained from the amplification of the positive test panel with the diagnostic fragment obtained from the amplification of the negative test panel whereby at least one highly conserved region in the diagnostic fragment of the positive test panel is identified which is at least 90% homologous to the corresponding positive test panel of diagnostic fragment; (C) designing amplification primers corresponding to the at least one Listeria genus-specific diagnostic marker selected in step (B); and (D) amplifying genomic DNA of the unknown bacterium under suitable annealing temperatures with the amplification primers of step (C), whereby obtaining amplification products indicates that the unknown bacterium is a member of the genus Listeria. 9. The method of Claim 8 wherein at step (A) the diagnostic fragment is at least 83% homologous to any one of SEQ LD NOS:24-31 and 33-40. 10. The method of Claim 8 wherein at step (A) the diagnostic fragment is selected from the group consisting of nucleic acids corresponding to SEQ ED NOS:24-31 and 33-40. 1 1. The method of Claim 8 wherein the Listeria monocytogenes pre- marker diagnostic fragment is selected from the group consisting of nucleic acids corresponding to SEQ ED NOS:20-23. 12. The method of Claim 8 wherein the at least one diagnostic marker selected in step (B) is selected from the group consisting of nucleic acids corresponding to SEQ ED NOS:84-l 10. 13. The method of Claim 8 wherein the at least one amplification primer is about 15 to 30 bp in length. 14. The method of Claim 8 wherein the suitable annealing temperature is in the range of about 60 °C to 70 °C. 15. A method for determining whether an unknown bacterium is a Listeria monocytogenes, comprising contacting the genomic DNA of the unknown bacterium with a nucleic acid probe selected from the group consisting of nucleic acids corresponding to SEQ ED NOS:46-83, and then detecting hybridization of the nucleic acid probe with the genomic DNA. 16. A method for deteπnining whether an unknown bacterium is a Listeria monocytogenes comprising contacting the genomic DNA of the unknown bacterium with a nucleic acid probe selected from the group consisting of nucleic acids corresponding to SEQ ED NOS: 84-110, and then detecting hybridization of the nucleic acid probe with the genomic DNA. 17. Isolated nucleic acid fragments selected from the group consisting of nucleic acid fragments corresponding to SEQ ED NOS: 17 through 110. 18. An isolated nucleic acid fragment encoding the amino acid sequence as given in any one of SEQ ED NOS:32 and 41-45. 19. A nucleic acid fragment located on a diagnostic fragment of about 1300 bp and selected from the group consisting of nucleic acid fragments designated 1515(rc341x2)-26-363, 1515(rc341x2)-27-281, 1515-26-36, 1515-27-357, 1515-26-rc233, 1515(8585)-27-rc737, 1515(8585)-28-rc793 1515-30-76, 1515-30-88, 1515(8585)-30-624, 1515(8585)-30-rc483, 1515(8585)-30-rc555, 1515(8585)-30-rc573, 1515(8585)-30-rc824, the diagnostic fragment characterized by (A) at least 83% homology to any one of SEQ ED NOS :24-31 and 33-40; and (B) an open reading frame of about 855 bp contained within the diagnostic fragment, the open reading frame encoding an amino acid sequence of any one of SEQ ED NOS:32 and 41- 45.

Inventors: HAZEL JAMES WILLIAM, JENSEN MARK ANTON, HAZEL, JAMES, WILLIAM, JENSEN, MARK, ANTON
Applicants: DU PONT, HAZEL JAMES WILLIAM, JENSEN MARK ANTON, E.I. DU PONT DE NEMOURS AND COMPANY, HAZEL, JAMES, WILLIAM, JENSEN, MARK, ANTON
Application year: 1997
Main classification: C12Q1
IPC codes: C12Q1